<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2017.01961</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Porcine Models of Biofilm Infections with Focus on Pathomorphology</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Jensen</surname> <given-names>Louise K.</given-names></name>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/419271/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Johansen</surname> <given-names>Anne S. B.</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/455301/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Jensen</surname> <given-names>Henrik E.</given-names></name>
</contrib>
</contrib-group>
<aff><institution>Section for Experimental Animal Models, Department of Veterinary and Animal Science, Faculty of Health and Medical Science, University of Copenhagen</institution>, <addr-line>Frederiksberg</addr-line>, <country>Denmark</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Sara Mar&#x000ED;a Soto, ISGlobal, Spain</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Paul Cos, University of Antwerp, Belgium; Devendra Hiraman Dusane, The Ohio State University Columbus, United States; Dipankar Ghosh, Jawaharlal Nehru University, India</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Louise K. Jensen <email>louise-k&#x00040;sund.ku.dk</email></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>1961</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>06</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>09</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Jensen, Johansen and Jensen.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Jensen, Johansen and Jensen</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p>Bacterial biofilm formation is one of the main reasons for a negative treatment outcome and a high recurrence rate for many chronic infections in humans. The optimal way to study both the biofilm forming bacteria and the host response simultaneously is by using discriminative, reliable, and reproducible animal models of the infections. In this review, the advantages of <italic>in vivo</italic> studies are compared to <italic>in vitro</italic> studies of biofilm formation in infectious diseases. The pig is the animal of choice when developing and applying large animal models of infectious diseases due to its similarity of anatomy, physiology, and immune system to humans. Furthermore, conventional pigs spontaneously develop many of the same chronic bacterial infections as seen in humans. Therefore, in this review porcine models of five different infectious diseases all associated with biofilm formation and chronicity in humans are described. The infectious diseases are: chronic wounds, endocarditis, pyelonephritis, hematogenous osteomyelitis, and implant-associated osteomyelitis (IAO).</p></abstract>
<kwd-group>
<kwd>biofilm</kwd>
<kwd>pig</kwd>
<kwd>animal model</kwd>
<kwd>hematogenous osteomyelitis</kwd>
<kwd>implant-associated osteomyelitis</kwd>
<kwd>chronic wounds</kwd>
<kwd>endocarditis</kwd>
<kwd>pyelonephritis</kwd>
</kwd-group>
<contract-num rid="cn001">4005-00035B</contract-num>
<contract-num rid="cn002">634588</contract-num>
<contract-sponsor id="cn001">Teknologi og Produktion, Det Frie Forskningsr&#x000E5;d<named-content content-type="fundref-id">10.13039/100008393</named-content></contract-sponsor>
<contract-sponsor id="cn002">Horizon 2020<named-content content-type="fundref-id">10.13039/501100007601</named-content></contract-sponsor>
<counts>
<fig-count count="3"/>
<table-count count="6"/>
<equation-count count="0"/>
<ref-count count="81"/>
<page-count count="16"/>
<word-count count="10178"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Chronic bacterial infections are a major healthcare problem and of increasing concern due to their high burden with respect to economic costs, increased bacterial antibiotic resistance, high morbidity, and mortality (Archer et al., <xref ref-type="bibr" rid="B3">2011</xref>; Roberts et al., <xref ref-type="bibr" rid="B67">2015</xref>). Biofilm forming bacteria have increased tolerance toward antimicrobials as well as mechanical removal and are one of the reasons why chronic bacterial infections are difficult to treat (Costerton et al., <xref ref-type="bibr" rid="B15">1999</xref>; Stewart, <xref ref-type="bibr" rid="B72">2014</xref>). In order to study bacterial biofilms in chronic infections, it is important to have discriminative and reproducible animal models (Costerton et al., <xref ref-type="bibr" rid="B15">1999</xref>; Bjarnsholt, <xref ref-type="bibr" rid="B5">2013</xref>). The pig resembles humans anatomically, physiologically and immunologically. Furthermore, conventional pigs spontaneously (naturally occurring infections) develop many of the same chronic bacterial infections as seen in humans (Harris and Alexander, <xref ref-type="bibr" rid="B30">1999</xref>). Therefore, it is possible to induce the disease experimentally in a discriminative way making the pig a reliable model for the study of biofilm related infectious diseases. This is not the case for many spontaneous infections in rodents, which do not adequately represent features of human disorders. In general, the use of pigs as experimental animals is intensely increasing and it is reasonable to expect that more porcine models of bacterial biofilm infections will be developed in the future. Therefore, the aim of the present paper is to review and describe existing porcine models of bacterial biofilm infections in humans with special focus on pathomorphology.</p>
<sec>
<title>Biofilm</title>
<p>Biofilm was described by Burm&#x000F8;lle et al. (<xref ref-type="bibr" rid="B10">2010</xref>) as: &#x0201C;A coherent cluster of bacterial cells imbedded in a biopolymer matrix, which, compared with planktonic cells, shows increased tolerance to antimicrobials and resists the antimicrobial properties of the host defense&#x0201D; (Burm&#x000F8;lle et al., <xref ref-type="bibr" rid="B10">2010</xref>).</p>
<p>In other descriptions of biofilm it is stated that either an abiotic or a biotic surface must be present for biofilm to form (Costerton et al., <xref ref-type="bibr" rid="B14">1995</xref>, <xref ref-type="bibr" rid="B15">1999</xref>; Davey and O&#x00027;toole, <xref ref-type="bibr" rid="B19">2000</xref>; Flemming and Wingender, <xref ref-type="bibr" rid="B27">2010</xref>). It has however, also been suggested that biofilm does not need a surface in order to be established, as bacteria may attach to each other and form biofilm (Donlan and Costerton, <xref ref-type="bibr" rid="B24">2002</xref>; Archer et al., <xref ref-type="bibr" rid="B3">2011</xref>; Bjarnsholt, <xref ref-type="bibr" rid="B5">2013</xref>). Another important characteristic of biofilm, is that the bacteria change phenotypic expression in regard to growth, gene expression and protein synthesis (Costerton et al., <xref ref-type="bibr" rid="B14">1995</xref>, <xref ref-type="bibr" rid="B15">1999</xref>, <xref ref-type="bibr" rid="B16">2003</xref>; Davey and O&#x00027;toole, <xref ref-type="bibr" rid="B19">2000</xref>; Brady et al., <xref ref-type="bibr" rid="B8">2008</xref>; Burm&#x000F8;lle et al., <xref ref-type="bibr" rid="B10">2010</xref>). In a study by Costerton et al. (<xref ref-type="bibr" rid="B16">2003</xref>), it was observed that all chronic bacterial diseases examined during a 12 year period, contained biofilm (Costerton et al., <xref ref-type="bibr" rid="B16">2003</xref>). Moreover, it has been recommended that all refractory chronic bacterial diseases should be analyzed for the presence of biofilm (Donlan and Costerton, <xref ref-type="bibr" rid="B24">2002</xref>).</p>
<p>Bacteria form biofilm in a number of situations: (1) it can be a defense mechanism when bacteria are in a hostile environment, (2) it can serve as a favorable habitat, if the bacteria are in an environment with a low amount of nutrients and (3) it can result from a mutation or a so called default mode of the bacteria (Bjarnsholt, <xref ref-type="bibr" rid="B5">2013</xref>).</p>
<p>The initiation of biofilm formation is usually mediated by flagella and/or pili (Costerton et al., <xref ref-type="bibr" rid="B15">1999</xref>). After adhering to other bacteria and/or a surface, a monolayer of bacteria is formed and develops into micro-colonies (Costerton et al., <xref ref-type="bibr" rid="B15">1999</xref>). Following formation of micro-colonies the extracellular matrix is formed (Costerton et al., <xref ref-type="bibr" rid="B15">1999</xref>). The matrix, which can be formed within 48 h after infection, is usually produced by the bacteria (Davis et al., <xref ref-type="bibr" rid="B21">2007</xref>; Bjarnsholt, <xref ref-type="bibr" rid="B5">2013</xref>). However, sometimes host components are also embedded within biofilm (Bjarnsholt, <xref ref-type="bibr" rid="B5">2013</xref>; Stewart, <xref ref-type="bibr" rid="B72">2014</xref>). The matrix consists of several components; proteins, lipids, extracellular DNA, polysaccharides, and other bacterial macromolecular components. Moreover, it has been realized that different bacteria are embedded in different components of biofilm matrix (Bjarnsholt, <xref ref-type="bibr" rid="B5">2013</xref>).</p>
<p>An increased tolerance of biofilm forming bacteria is seen toward antimicrobials which may be due to a number of factors. Matrix may possess the ability to bind and inactivate antibacterial agents (Bjarnsholt, <xref ref-type="bibr" rid="B5">2013</xref>). Furthermore, bacteria growing as a biofilm are less metabolically active, due to the decreased amounts of nutrients available, making them more tolerant to several antimicrobials (Bjarnsholt, <xref ref-type="bibr" rid="B5">2013</xref>). In addition, bacteria in biofilm also show increased tolerance toward the host&#x00027;s immune system (Bjarnsholt, <xref ref-type="bibr" rid="B5">2013</xref>; Stewart, <xref ref-type="bibr" rid="B72">2014</xref>). The mechanism behind this has not been fully elucidated, but it appears that the presence of biofilm constantly stimulates polymorphonuclear leucocytes (PMNs). PMNs are, however, not able to phagocytize biofilm, presumably due to the size of the biofilm, leading to the phenomenon &#x0201C;frustrated phagocytosis&#x0201D; (Bjarnsholt, <xref ref-type="bibr" rid="B5">2013</xref>; Stewart, <xref ref-type="bibr" rid="B72">2014</xref>). The role of the adaptive immune response has not been fully clarified with respect to biofilm. Although, in <italic>Staphylococcus aureus</italic> biofilm it has been realized that several factors inhibits the activation and effects of the adaptive immune response (Kim et al., <xref ref-type="bibr" rid="B48">2012</xref>).</p>
<p>Several methods have been applied in order to demonstrate biofilm formation and function, in relation to different infectious diseases (Lebeaux et al., <xref ref-type="bibr" rid="B51">2013</xref>). It has been proven difficult to culture biofilm embedded bacteria and some samples may need ultra-sonication before cultivation (Burm&#x000F8;lle et al., <xref ref-type="bibr" rid="B10">2010</xref>). Other methods used to identify biofilm embedded bacteria include peptide nucleic acid fluorescence <italic>in situ</italic> hybridization (PNA FISH; Figure <xref ref-type="fig" rid="F1">1B</xref>), electron microscopy, immunohistochemistry staining, and confocal scanning laser microscopy (CSLM; Costerton et al., <xref ref-type="bibr" rid="B15">1999</xref>; Bjarnsholt, <xref ref-type="bibr" rid="B5">2013</xref>). CSLM is becoming the method of choice, as it enables analysis of a fully hydrated and living biofilm <italic>in situ</italic> (Figures <xref ref-type="fig" rid="F1">1C,D</xref>; Costerton et al., <xref ref-type="bibr" rid="B14">1995</xref>; Kirketerp-M&#x000F8;ller et al., <xref ref-type="bibr" rid="B49">2008</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>(A)</bold> Chronic venous leg ulcer. <bold>(B)</bold> Biofilm of <italic>P. aeruginosa</italic> [red stain] and <italic>S. aureus</italic> [green stain], identified by specific PNA FISH probes, surrounded by host cells (DAPI [blue stain]) in a human chronic wound. <bold>(C)</bold> CSLM three dimensional imaging of picture B. <bold>(D)</bold> Enlargement of picture C. The white arrows point to bacterial aggregates and the yellow arrows point to the wound surface (Kirketerp-M&#x000F8;ller et al., <xref ref-type="bibr" rid="B49">2008</xref>).</p></caption>
<graphic xlink:href="fmicb-08-01961-g0001.tif"/>
</fig>
</sec>
<sec>
<title>Biofilm <italic>in Vitro</italic> and <italic>in Vivo</italic></title>
<p>Several approaches have been applied to study the complexity of bacterial biofilms. <italic>In vitro</italic> experiments were used in the early studies of biofilm and much knowledge about biofilm physiology and formation has been achieved using <italic>in vitro</italic> models (Bjarnsholt et al., <xref ref-type="bibr" rid="B6">2013</xref>; Lebeaux et al., <xref ref-type="bibr" rid="B51">2013</xref>). However, <italic>in vitro</italic> and also <italic>ex-vivo</italic> (Yang et al., <xref ref-type="bibr" rid="B79">2017</xref>) studies have to be supplemented with <italic>in vivo</italic> studies if the response of the immune system toward bacterial biofilm infections is investigated (Rumbaugh and Carty, <xref ref-type="bibr" rid="B69">2011</xref>; Roberts et al., <xref ref-type="bibr" rid="B67">2015</xref>). This was also recently demonstrated with references to porcine infections due to <italic>Actinobacillus pleuropneumoniea</italic> (Tremblay et al., <xref ref-type="bibr" rid="B77">2017</xref>).</p>
<p>Biofilm formation <italic>in vitro</italic> and <italic>in vivo</italic> is significantly different with respect to a number of characteristics (Bjarnsholt et al., <xref ref-type="bibr" rid="B6">2013</xref>). <italic>In vitro</italic> biofilm of <italic>Pseudomonas aeruginosa</italic> forms &#x0201C;mushroom&#x0201D; like structures (Bjarnsholt, <xref ref-type="bibr" rid="B5">2013</xref>; Ghanbari et al., <xref ref-type="bibr" rid="B29">2016</xref>), which are not observed <italic>in vivo</italic> (Bjarnsholt et al., <xref ref-type="bibr" rid="B6">2013</xref>). Another important difference is that <italic>in vitro</italic> biofilm is solely made up by bacterial derived components, whereas <italic>in vivo</italic> biofilm contains a mixture of bacterial and host derived elements (Bjarnsholt, <xref ref-type="bibr" rid="B5">2013</xref>; Stewart, <xref ref-type="bibr" rid="B72">2014</xref>). The size of biofilm formations is also different <italic>in vitro</italic> compared to <italic>in vivo</italic>. <italic>In vivo</italic> biofilms have a maximum diameter of 200 &#x003BC;m, whereas <italic>in vitro</italic> biofilm can reach up to several centimeters (Bjarnsholt et al., <xref ref-type="bibr" rid="B6">2013</xref>). The limitation in size has been suggested to be related to oxygen depletion in the local environment (Roberts et al., <xref ref-type="bibr" rid="B67">2015</xref>). Finally, the infectious biofilm formation <italic>in vivo</italic>, also enables the study of the host immune response toward biofilm (Coenye and Nelis, <xref ref-type="bibr" rid="B13">2010</xref>). The pros and cons for <italic>in vitro</italic> and <italic>in vivo</italic> studies of bacterial biofilms are shown in Table <xref ref-type="table" rid="T1">1</xref> (Lebeaux et al., <xref ref-type="bibr" rid="B51">2013</xref>).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Pros and cons of studying biofilm in regard to bacterial diseases <italic>in Vitro</italic> vs. <italic>in Vivo</italic>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th/>
<th valign="top" align="left"><bold>Pros</bold></th>
<th valign="top" align="left"><bold>Cons</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left"><italic><bold>In vitro</bold></italic></td>
<td valign="top" align="left">Simple</td>
<td valign="top" align="left">No host influence</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Reproducible</td>
<td valign="top" align="left">Inferior in treatment studies</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Cheap</td>
<td valign="top" align="left">&#x0201C;Mushroom&#x0201D; structure</td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td/>
<td valign="top" align="left">Non-invasive</td>
<td/>
</tr> <tr>
<td valign="top" align="left"><italic><bold>In vivo</bold></italic></td>
<td valign="top" align="left">Host influence</td>
<td valign="top" align="left">Expensive</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Ideal in treatment studies</td>
<td valign="top" align="left">Complex</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Natural biofilm formation</td>
<td valign="top" align="left">Biological variation</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Invasive</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s2">
<title>Comparative anatomy, physiology, and immunology of pigs and humans</title>
<p>Several different animal models have been applied in order to study biofilm <italic>in vivo</italic>. In relation to chronic bacterial diseases, mice, rats, and rabbits have been used most frequently (Rumbaugh and Carty, <xref ref-type="bibr" rid="B69">2011</xref>). Only a few large animal models using pigs, sheep, goats, monkeys, and dogs have been developed (Rumbaugh and Carty, <xref ref-type="bibr" rid="B69">2011</xref>). In recent years, the use of pigs as experimental animals has increased. Pigs have especially been applied in studies of toxicity, metabolism, cancer, dermatology, cardiology, and neurology (Swindle et al., <xref ref-type="bibr" rid="B75">2012</xref>). However, during the last ten years several porcine models of bacterial diseases have been developed (Isling et al., <xref ref-type="bibr" rid="B34">2011</xref>; Meurens et al., <xref ref-type="bibr" rid="B57">2012</xref>; Christiansen et al., <xref ref-type="bibr" rid="B12">2013b</xref>; Jensen et al., <xref ref-type="bibr" rid="B39">2017</xref>). Figures <xref ref-type="fig" rid="F2">2</xref>, <xref ref-type="fig" rid="F3">3</xref> shows the diversity of the pig as a model for human bacterial diseases. An advantage of using pigs as a model for bacterial infections is their immune response, which is quite comparable to that of humans (Meurens et al., <xref ref-type="bibr" rid="B57">2012</xref>). In a study comparing the porcine, and human genome it was found that there is a 78% similarity, both structurally and functionally, between human and porcine immune related proteins (Dawson, <xref ref-type="bibr" rid="B22">2011</xref>). The population of immune cells in humans and pigs is also alike. As in humans, pigs have a large percentage of PMNs in the peripheral blood (Meurens et al., <xref ref-type="bibr" rid="B57">2012</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Establishment of four different models in conventional pigs of 30 kg. <bold>(A)</bold> Implant associated osteomyelitis, a drill hole is created in the right tibia followed by injection of bacteria and insertion of a small metal implant (Jensen et al., <xref ref-type="bibr" rid="B39">2017</xref>). <bold>(B)</bold> Intravenous inoculation of bacteria for induction of endocarditis. Four days prior to inoculation, a permanent catheter was placed in the left ventricle (Christiansen et al., <xref ref-type="bibr" rid="B12">2013b</xref>). <bold>(C)</bold> Free dissection of the right ureter, followed by insertion of a catheter used for inoculation of bacteria directly in the renal pelvis (Isling et al., <xref ref-type="bibr" rid="B34">2011</xref>). <bold>(D)</bold> Four wounds created on the back at different time intervals for bacterial inoculation.</p></caption>
<graphic xlink:href="fmicb-08-01961-g0002.tif"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Left column: chronic spontaneous bacterial infections in conventional pigs <bold>(A&#x02013;D)</bold> and a human <bold>(E)</bold>. Middle column: experimental porcine models of human infections. Right column (except from picture A3): microscopy of the lesions present in the middle column. Row A: Chronic wounds. <bold>A1</bold>: Shoulder ulceration. <bold>A2</bold>: wound located on the back. <bold>A3</bold>: Bacteria (arrow) in a shoulder ulceration from a conventional pig. Row B: Endocarditis. <bold>B1</bold>: Left side, thrombotic valvular endocarditis (arrow). <bold>B2</bold>: A permanent catheter (arrow) inserted into the left ventricle prior to inoculation of bacteria. <bold>B3</bold>: Immunohistochemical staining of <italic>S. aureus</italic> (arrow) on the mitral valve (Christiansen et al., <xref ref-type="bibr" rid="B12">2013b</xref>). Row C: Pyelonephritis. <bold>C1, C2</bold>: Polar located lesions of pyelonephritis (arrows). <bold>C3</bold>: Immunohistochemical staining of <italic>E. coli</italic> (arrows) in the proximal tubuli (Isling et al., <xref ref-type="bibr" rid="B34">2011</xref>). Row D: Hematogenous osteomyelitis. <bold>D1, D2</bold>: Purulent osteomyelitis (O) in the femur. <bold>D3</bold>: Immunohistochemical staining of <italic>S. aureus</italic> (arrow) located in the capillary loops of the metaphysis (Johansen et al., <xref ref-type="bibr" rid="B43">2012b</xref>). Row E: Implant-associated osteomyelitis. <bold>E1</bold>: Infected osteo-syntheses of the ankle. <bold>E2</bold>: Peri-implant infected bone tissue (double arrow) surrounding the implant cavity (ic), the implant has been removed. <bold>E3</bold>: Immunohistochemical staining of <italic>S. aureus</italic> (arrow) and in the insert (Jensen et al., <xref ref-type="bibr" rid="B39">2017</xref>).</p></caption>
<graphic xlink:href="fmicb-08-01961-g0003.tif"/>
</fig>
<p>Porcine models can be based on conventional pigs or mini-pigs of different breeds. The growth rate of conventional pigs is high (1 kg at birth, 100 kg at 4 months and the body weight of an adult is &#x0003E;200 kg) compared to mini-pigs (0.5 kg at birth, 12&#x02013;14 kg at 4 months and the body weight of an adult is 40&#x02013;80 kg), making mini-pigs a more favorable model for adults (Swindle et al., <xref ref-type="bibr" rid="B75">2012</xref>). Pigs are available as outbred and inbred. Using inbred pigs will allow a more uniform outcome of studies, in which the outbred pigs will allow the impact of biological diversity, just as in the human population (Meurens et al., <xref ref-type="bibr" rid="B57">2012</xref>). Furthermore, the health status and full pedigree can usually be acquired for both conventional pigs and mini-pigs (Meurens et al., <xref ref-type="bibr" rid="B57">2012</xref>). Min-pigs are available from Sinclair Bioresource (Hanford, Sinclair, Yucatan, Yucatan Micro) and Ellegaard G&#x000F6;ttingen Minipigs (G&#x000F6;ttingen Minipigs). Conventional pigs are supplied by conventional farmers.</p>
</sec>
<sec id="s3">
<title>Porcine models of chronic bacterial infectious diseases</title>
<p>Pigs have been used to model the following chronic bacterial diseases, all known to be associated with biofilm formation in humans; chronic wounds, endocarditis, pyelonephritis, hematogenous osteomyelitis, and implant-associated osteomyelitis (IAO). In this review, these models will be described and the advantages of using pigs as a model for the five diseases will be elucidated with regard to how pigs are comparable to human&#x00027;s skin, heart, kidneys, and bones.</p>
<p>The inclusion and exclusion criteria for this review: The keywords &#x0201C;porcine model,&#x0201D; &#x0201C;biofilm,&#x0201D; &#x0201C;chronic wounds,&#x0201D; &#x0201C;endocarditis,&#x0201D; &#x0201C;pyelonephritis,&#x0201D; &#x0201C;hematogenous osteomyelitis,&#x0201D; &#x0201C;implant-associated osteomyelitis&#x0201D; were searched for in different combinations. The primary databases used were Google Scholar, REX, Web of Science and PubMed. The criteria which the studies had to fulfill in order to be enclosed in this review were as follows;</p>
<list list-type="order">
<list-item><p>It had to be a study of chronic wounds, endocarditis, pyelonephritis, hematogenous osteomyelitis, or implant-associated osteomyelitis.</p></list-item>
<list-item><p>The study had to use a porcine model.</p></list-item>
<list-item><p>The pigs had to be inoculated with bacteria in order to develop infection.</p></list-item>
</list>
</sec>
<sec id="s4">
<title>Porcine models of chronic wounds</title>
<p>Pigs are commonly applied in experimental wound studies (Figure <xref ref-type="fig" rid="F3">3A2</xref>). The skin of pigs is comparable to that of humans in a number of ways. Pig skin has little hair and is well attached to the subcutaneous layer, as in humans (Swindle and Smith, <xref ref-type="bibr" rid="B74">1998</xref>). Wound healing in pigs has been found to be similar to that of humans (Sullivan et al., <xref ref-type="bibr" rid="B73">2001</xref>). The major differences are the cutaneous blood supply as well as the thickness of the skin (Swindle and Smith, <xref ref-type="bibr" rid="B74">1998</xref>; Liu et al., <xref ref-type="bibr" rid="B53">2010</xref>). Although the thickness of the skin is greater in pigs, the ratio between dermis and epidermis is similar to that of humans (Meurens et al., <xref ref-type="bibr" rid="B57">2012</xref>). The subcutis in pigs is divided into three different layers, which are all separated by fascia (Driskell et al., <xref ref-type="bibr" rid="B25">2014</xref>). In humans, the subcutis is only divided into two layers (Driskell et al., <xref ref-type="bibr" rid="B25">2014</xref>). Finally, the sweat glands in porcine skin are all apocrine, whereas in humans eccrine sweat glands are dominating (Liu et al., <xref ref-type="bibr" rid="B53">2010</xref>).</p>
<p>The pig is suitable as a model for chronic wounds due to its similarity to humans with respect to the structure of the skin, but also because chronic wounds regularly are found in conventional pigs. Accidentally occurring chronic wounds may be found all over the skin of pigs; however, In recent years focus has been on shoulder ulcerations in sows (Figure <xref ref-type="fig" rid="F3">3A1</xref>). Shoulder ulcerations in pigs are caused by pressure and the pathogenesis is a progression of damage from the top and down through the dermal layers (Maxie, <xref ref-type="bibr" rid="B55">2007</xref>; Jensen, <xref ref-type="bibr" rid="B35">2009</xref>; Schomberg et al., <xref ref-type="bibr" rid="B70">2016</xref>). This pathogenesis is also seen in humans, however, a &#x0201C;reversed&#x0201D; pathogenesis, in which the progression can be from the inside and out is also seen in humans (Anderson, <xref ref-type="bibr" rid="B2">1976</xref>). A major difference in the pathogenesis of human pressure ulceration is that they can be complicated by osteitis/osteomyelitis, which has not been associated with pressure ulcers in pigs (Jensen, <xref ref-type="bibr" rid="B35">2009</xref>). Another important difference between pressure ulcers in humans and pigs is that in pigs, they occur in otherwise healthy individuals, whereas in humans they usually develop due to an underlying disease (Dahl-Pedersen et al., <xref ref-type="bibr" rid="B17">2013</xref>). In humans, the most important pathogen in chronic wounds is <italic>S. aureus</italic> (Bowler, <xref ref-type="bibr" rid="B7">2002</xref>), whereas <italic>Trueperella pyogenes</italic> is the most common pathogen in shoulder ulcerations of sows (Lund, <xref ref-type="bibr" rid="B54">2003</xref>; Dahl-Pedersen et al., <xref ref-type="bibr" rid="B17">2013</xref>). Along with pressure ulcers, there are two other types of chronic wounds, which dominate in humans; diabetic ulcers and venous ulcers (Figure <xref ref-type="fig" rid="F1">1A</xref>; Medina et al., <xref ref-type="bibr" rid="B56">2005</xref>). Although diabetic and venous ulcers do not occur in pigs under natural circumstances, the pig has been used as a model for diabetic wounds (Seaton et al., <xref ref-type="bibr" rid="B71">2015</xref>). Porcine models of burn wounds and hypertrophic scars have also been developed (Seaton et al., <xref ref-type="bibr" rid="B71">2015</xref>). In 2003 Breuing et al. established a partial thickness burn wound model with <italic>S. aureus</italic> as inoculum (Table <xref ref-type="table" rid="T2">2</xref>). They used a chamber to cover the burn wound, by which it was possible to study the wounds continuously (Breuing et al., <xref ref-type="bibr" rid="B9">2003</xref>). Davis et al. (<xref ref-type="bibr" rid="B21">2007</xref>) created a partial thickness wound using an electrokeratome, which was also inoculated with <italic>S. aureus</italic>. By using electron microscopy and epifluorescence microscopy (Table <xref ref-type="table" rid="T2">2</xref>), they demonstrated the formation of biofilm after 48 h. Furthermore, they also showed that biofilm could not be eradicated with the antibiotics tested (Davis et al., <xref ref-type="bibr" rid="B21">2007</xref>). A novel full thickness diabetic wound model developed by Hirsch et al. (<xref ref-type="bibr" rid="B31">2008</xref>) showed that diabetic pigs maintained a significant infection compared to the non-diabetic pigs (Table <xref ref-type="table" rid="T2">2</xref>). Furthermore, a significant delay in wound healing was found in the diabetic wounds (Hirsch et al., <xref ref-type="bibr" rid="B31">2008</xref>). A full thickness wound model by Roche et al. (<xref ref-type="bibr" rid="B68">2012</xref>; Table <xref ref-type="table" rid="T2">2</xref>), showed that biofilm formation resulted in delayed healing (Roche et al., <xref ref-type="bibr" rid="B68">2012</xref>). Nusbaum et al. (<xref ref-type="bibr" rid="B60">2012</xref>) inoculated <italic>S. aureus</italic> into a deep dermal wound model (Table <xref ref-type="table" rid="T2">2</xref>) in order to study the effect of different types of wound debridement: plasma-mediated bipolar radiofrequency ablation, hydrosurgery system, and sharp debridement. They achieved a significant reduction of bacteria in all debridement groups and a significant reduction of <italic>S. aureus</italic> in the plasma-mediated bipolar radiofrequency ablation groups (Nusbaum et al., <xref ref-type="bibr" rid="B60">2012</xref>). Finally, a full thickness porcine wound model was established using <italic>P. aeruginosa</italic> as inoculum (Table <xref ref-type="table" rid="T2">2</xref>). In the model, the effect of different therapeutical strategies using negative pressure wound therapy was evaluated (Davis et al., <xref ref-type="bibr" rid="B20">2013</xref>).</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Porcine models of chronic wounds.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>References (year)</bold></th>
<th valign="top" align="center" colspan="8" style="border-bottom: thin solid #000000;"><bold>Model design</bold></th>
<th valign="top" align="center" colspan="4" style="border-bottom: thin solid #000000;"><bold>Inoculum</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Outcome</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="center"><bold>Number of animals</bold></th>
<th valign="top" align="center"><bold>Age (weeks)</bold></th>
<th valign="top" align="center"><bold>Weight (kg)</bold></th>
<th valign="top" align="left"><bold>Sex</bold></th>
<th valign="top" align="left"><bold>Breed</bold></th>
<th valign="top" align="center"><bold>Number of wounds</bold></th>
<th valign="top" align="left"><bold>Infection time</bold></th>
<th valign="top" align="left"><bold>Implant/modification</bold></th>
<th valign="top" align="left"><bold>Bacteria</bold></th>
<th valign="top" align="center"><bold>Dose CFU/ml</bold></th>
<th valign="top" align="center"><bold>Volume</bold></th>
<th valign="top" align="center"><bold>Route</bold></th>
<th valign="top" align="left"><bold>Bacterial verification T/I</bold></th>
<th valign="top" align="left"><bold>Infection stage</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Breuing et al., <xref ref-type="bibr" rid="B9">2003</xref></td>
<td valign="top" align="center">3</td>
<td valign="top" align="left">24</td>
<td valign="top" align="center">45</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">Yorkshire</td>
<td valign="top" align="center">48</td>
<td valign="top" align="left">2&#x02013;47 days</td>
<td valign="top" align="left">Partial thickness (burn) wounds Wound chamber</td>
<td valign="top" align="left"><italic>S. aureus</italic> MRSA 25923</td>
<td valign="top" align="center">10<sup>8</sup></td>
<td valign="top" align="center">1.2 ml</td>
<td valign="top" align="center">Topical</td>
<td valign="top" align="left">T: CFU &#x0002B; Histology I: NA</td>
<td valign="top" align="left">Acute</td>
</tr>
<tr>
<td valign="top" align="left">Davis et al., <xref ref-type="bibr" rid="B21">2007</xref></td>
<td valign="top" align="center">6</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="center">25&#x02013;35</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="center">&#x0003C;279</td>
<td valign="top" align="left">48 h</td>
<td valign="top" align="left">Partial thickness wounds Wound dressing</td>
<td valign="top" align="left"><italic>S. aureus</italic> ATCC 6,538</td>
<td valign="top" align="center">10<sup>7</sup></td>
<td valign="top" align="center">NR</td>
<td valign="top" align="center">Topical</td>
<td valign="top" align="left">T: Histology &#x0002B; SEM &#x0002B; EpiM I: NA</td>
<td valign="top" align="left">Acute</td>
</tr>
<tr>
<td valign="top" align="left">Hirsch et al., <xref ref-type="bibr" rid="B31">2008</xref></td>
<td valign="top" align="center">4</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="center">50&#x02013;60</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">Yorkshire (&#x000B1;diabetic)</td>
<td valign="top" align="center">56</td>
<td valign="top" align="left">12 days</td>
<td valign="top" align="left">Full thickness (diabetic) wounds Wound chamber</td>
<td valign="top" align="left"><italic>S. aureus</italic> MRSA 25923</td>
<td valign="top" align="center">2 &#x000D7; 10<sup>8</sup></td>
<td valign="top" align="center">NR</td>
<td valign="top" align="center">Topical</td>
<td valign="top" align="left">T: CFU &#x0002B; Histology I: NA</td>
<td valign="top" align="left">Chronic</td>
</tr>
<tr>
<td valign="top" align="left">Roche et al., <xref ref-type="bibr" rid="B68">2012</xref></td>
<td valign="top" align="center">40</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="center">20&#x02013;25</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">Yorkshire crossbred</td>
<td valign="top" align="center">640&#x02013;800</td>
<td valign="top" align="left">21 days</td>
<td valign="top" align="left">Full thickness wounds Wound dressing</td>
<td valign="top" align="left"><italic>S. aureus</italic> MRSA ATCC 33592&#x0002B;PJR006</td>
<td valign="top" align="left">1 &#x000D7; 10<sup>7</sup> 1 &#x000D7; 10<sup>8</sup></td>
<td valign="top" align="center">0.5 or 2 ml</td>
<td valign="top" align="center">Topical</td>
<td valign="top" align="left">T: CFU &#x0002B; Histology &#x0002B; SEM I: NA</td>
<td valign="top" align="left">Chronic</td>
</tr>
<tr>
<td valign="top" align="left">Nusbaum et al., <xref ref-type="bibr" rid="B60">2012</xref></td>
<td valign="top" align="center">9</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="center">35&#x02013;40</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="center">135</td>
<td valign="top" align="left">23 days</td>
<td valign="top" align="left">Partial thickness Wound dressing</td>
<td valign="top" align="left"><italic>S. aureus</italic> MRSA USA300</td>
<td valign="top" align="center">10<sup>6</sup></td>
<td valign="top" align="center">25 &#x003BC;l</td>
<td valign="top" align="center">Topical</td>
<td valign="top" align="left">T: CFU &#x0002B; Histology I: NA</td>
<td valign="top" align="left">Chronic</td>
</tr>
<tr>
<td valign="top" align="left">Davis et al., <xref ref-type="bibr" rid="B20">2013</xref></td>
<td valign="top" align="center">6</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="center">40&#x02013;55</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="center">36</td>
<td valign="top" align="left">21 days</td>
<td valign="top" align="left">Full thickness wounds Wound dressing</td>
<td valign="top" align="left"><italic>P. aeruginosa</italic> 6538</td>
<td valign="top" align="center">500</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="center">Topical</td>
<td valign="top" align="left">T: PCR &#x0002B; CFU I: NA</td>
<td valign="top" align="left">Chronic</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>T, verification method in tissue; I, verification method on implant; CFU, colony forming units; SEM, scanning electron microscopy; EpiM, epifluorescence microscopy; NR, not registered; F, female. NA, not available</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s5">
<title>Porcine models of endocarditis</title>
<p>Due to porcine similarities in the cardiovascular system, pigs have been used as a model in a number of cardiac studies, e.g., transplantation, experimental atherosclerosis, and endocarditis (Swindle et al., <xref ref-type="bibr" rid="B75">2012</xref>; Schomberg et al., <xref ref-type="bibr" rid="B70">2016</xref>). The hemodynamics of the porcine cardiovascular system is similar to humans, however, there are differences between different breeds and ages of pigs (Swindle and Smith, <xref ref-type="bibr" rid="B74">1998</xref>; Swindle et al., <xref ref-type="bibr" rid="B75">2012</xref>). In contrast to humans, pigs have a large left azygos (hemiazygos) vein, which enters into the coronary sinus, instead of the superior vena cava (Swindle and Smith, <xref ref-type="bibr" rid="B74">1998</xref>; Swindle et al., <xref ref-type="bibr" rid="B75">2012</xref>). Another difference is that the semi-lunar valves in pigs are slightly smaller compared to that of humans (Ibrahim et al., <xref ref-type="bibr" rid="B33">2006</xref>). The hearts of pigs come in many different sizes, however, the heart of a mini-pig is equivalent to about 0.3&#x02013;0.5% of the total bodyweight, thus, a mini-pig of about 40&#x02013;50 kg, has a heart of similar size as an adult human (Swindle and Smith, <xref ref-type="bibr" rid="B74">1998</xref>).</p>
<p>Endocarditis occurs spontaneously in conventional pigs, and has been characterized, both histopathologically and microbiologically (Jensen et al., <xref ref-type="bibr" rid="B36">2010a</xref>). In pigs, the lesions of endocarditis are mainly located on the mitral valves, sometimes with secondary lesions in the adjacent mural wall (Figure <xref ref-type="fig" rid="F3">3B1</xref>). Histopathologically, the vegetation is generally made up of granulation tissue, surrounded by fibrin. However, vegetation made up of granulomatous inflammation with mineralization may be seen, particularly in <italic>Streptococcus</italic> infections (Jensen et al., <xref ref-type="bibr" rid="B36">2010a</xref>). Others have described the vegetation found in porcine endocarditis as &#x0201C;Cauliflower-like&#x0201D; (Geissinger et al., <xref ref-type="bibr" rid="B28">1973</xref>). In humans, the appearance of the lesion is similar to that of pigs. The lesions can be quite large and are also made up by fibrin, and the embedded bacteria are surrounded by leukocytes and granulation tissue (Anderson, <xref ref-type="bibr" rid="B2">1976</xref>). The most common infectious agents of porcine endocarditis are <italic>S. suis</italic> and <italic>Erysipelothrix rhusiopathiae</italic> (Jensen et al., <xref ref-type="bibr" rid="B36">2010a</xref>). In contrast, the most important pathogen in humans is <italic>S. aureus</italic> (Murdoch et al., <xref ref-type="bibr" rid="B59">2009</xref>). The pathogenesis in pigs has not been established, however, it is believed that there has to be a persistent or recurrent bacteremia (Maxie, <xref ref-type="bibr" rid="B55">2007</xref>). In humans, infectious endocarditis mainly develops secondary to a state of non-bacterial thrombotic endocarditis (Christiansen et al., <xref ref-type="bibr" rid="B12">2013b</xref>).</p>
<p>The first porcine model of endocarditis was described by Jones (<xref ref-type="bibr" rid="B45">1969</xref>) who established a non-traumatic endocarditis model, in which four different strains of <italic>Streptococci</italic> were inoculated intravenously. The strains were from Lancefield group C and L, respectively. Strain S85 (Group L), resulted in endocarditis in the pigs and was used in his further studies (Table <xref ref-type="table" rid="T3">3</xref>; Jones, <xref ref-type="bibr" rid="B45">1969</xref>, <xref ref-type="bibr" rid="B46">1981</xref>, <xref ref-type="bibr" rid="B47">1982</xref>). He found that macroscopic lesions developed as early as 18 h after inoculation and that the lesions in general matched those seen in humans (Jones, <xref ref-type="bibr" rid="B45">1969</xref>). Geissinger et al. (<xref ref-type="bibr" rid="B28">1973</xref>) did a study using both conventional and gnotobiotic pigs, where they inoculated the bacteria sub-cutaneously. In that study, they also used two different strains of <italic>S. aureus</italic> (A and B) as well as one strain of <italic>E. rhusiopathiae</italic>. The study showed that strain A of <italic>S. aureus</italic>, was the only one which resulted in endocarditis in both conventional and gnotobiotic pigs (Geissinger et al., <xref ref-type="bibr" rid="B28">1973</xref>). In another study by Jones (<xref ref-type="bibr" rid="B46">1981</xref>), he examined the lesions 3&#x02013;14 days after inoculation, using the same experimental procedure as in 1969 (Jones, <xref ref-type="bibr" rid="B46">1981</xref>). Finally, Jones examined the development of lesions 18&#x02013;48 h after inoculation. The lesions were again macroscopically visible 18 h after inoculation (Jones, <xref ref-type="bibr" rid="B47">1982</xref>). In 1986, Johnson et al. tried to reproduce the findings of Jones (Jones, <xref ref-type="bibr" rid="B45">1969</xref>, <xref ref-type="bibr" rid="B46">1981</xref>, <xref ref-type="bibr" rid="B47">1982</xref>), however, only 11% of the pigs developed endocarditis (Johnson et al., <xref ref-type="bibr" rid="B44">1986</xref>). Interestingly, insertion of a non-permanent catheter through the carotid artery and into the left ventricle followed by intravenous inoculation of <italic>Streptococci</italic> (Group C) resulted in endocarditis in 94% of the pigs (Johnson et al., <xref ref-type="bibr" rid="B44">1986</xref>). Another study using catheterization was done by Dewar et al. (<xref ref-type="bibr" rid="B23">1987</xref>) who used mini-pigs and inoculations of <italic>S. sanguis</italic> (Group H), which resulted in the development of endocarditis in 75% of the pigs (Dewar et al., <xref ref-type="bibr" rid="B23">1987</xref>). Recently, two studies were carried out by Christiansen et al. (<xref ref-type="bibr" rid="B11">2013a</xref>,<xref ref-type="bibr" rid="B12">b</xref>). In these studies a permanent catheter was also placed through the carotid artery and into the left side of the heart. The bacteria inoculated were two strains of <italic>S. aureus</italic> which were isolated from a pig and a human, respectively. The porcine strain produced endocarditis in both studies, using an inoculum dose of 10<sup>7</sup> CFU/ml, whereas infection by the human strain failed to induce endocarditis (Figures <xref ref-type="fig" rid="F3">3B2,B3</xref>; Christiansen et al., <xref ref-type="bibr" rid="B11">2013a</xref>,<xref ref-type="bibr" rid="B12">b</xref>).</p>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p>Porcine models of endocarditis.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>References (year)</bold></th>
<th valign="top" align="center" colspan="7" style="border-bottom: thin solid #000000;"><bold>Model design</bold></th>
<th valign="top" align="center" colspan="4" style="border-bottom: thin solid #000000;"><bold>Inoculum</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>Outcome</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="center"><bold>Number of animals</bold></th>
<th valign="top" align="center"><bold>Age (weeks)</bold></th>
<th valign="top" align="center"><bold>Weight (kg)</bold></th>
<th valign="top" align="left"><bold>Sex</bold></th>
<th valign="top" align="left"><bold>Breed</bold></th>
<th valign="top" align="left"><bold>Infection time</bold></th>
<th valign="top" align="left"><bold>Implant/modification</bold></th>
<th valign="top" align="left"><bold>Bacteria</bold></th>
<th valign="top" align="left"><bold>Dose CFU/ml</bold></th>
<th valign="top" align="center"><bold>Volume</bold></th>
<th valign="top" align="left"><bold>Route</bold></th>
<th valign="top" align="left"><bold>Bacterial verification T/I</bold></th>
<th valign="top" align="left"><bold>Infection stage</bold></th>
<th valign="top" align="left"><bold>Success rate<xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Jones, <xref ref-type="bibr" rid="B45">1969</xref></td>
<td valign="top" align="center">17</td>
<td valign="top" align="center">8&#x02013;12 and 12&#x02013;14</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="left">M/F</td>
<td valign="top" align="left">Yorkshire</td>
<td valign="top" align="left">2&#x02013;47 days</td>
<td valign="top" align="left">None</td>
<td valign="top" align="left"><italic>&#x003B2;-haemolytic Streptococci</italic> S21 and S57 (Group C) S34 and S85 (Group L)</td>
<td valign="top" align="left">10<sup>8</sup></td>
<td valign="top" align="center">10 ml</td>
<td valign="top" align="left">I.V.</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: NRV</td>
<td valign="top" align="left">Acute</td>
<td valign="top" align="left">S85: 77%</td>
</tr>
<tr>
<td valign="top" align="left">Geissinger et al., <xref ref-type="bibr" rid="B28">1973</xref></td>
<td valign="top" align="center">64</td>
<td valign="top" align="center">12&#x02013;20 and 3 or 10</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="left">M/F</td>
<td valign="top" align="left">Yorkshire Conventional and Gnotobiotic</td>
<td valign="top" align="left">2&#x02013;12 days</td>
<td valign="top" align="left">None</td>
<td valign="top" align="left">Two strains of <italic>S. aureus</italic> A and B <italic>E. rhusiopathiae</italic> P2-8</td>
<td valign="top" align="left">A: 2 &#x000D7; 10<sup>9</sup>&#x02013;9 &#x000D7; 10<sup>10</sup> B: 8 &#x000D7; 10<sup>11</sup> <italic>E. rhusiopathiae:</italic> 4 &#x000D7; 10<sup>10</sup></td>
<td valign="top" align="center">7-10 ml</td>
<td valign="top" align="left">S.C.</td>
<td valign="top" align="left">T: Histology (LM and SEM) I: NRV</td>
<td valign="top" align="left">Acute</td>
<td valign="top" align="left">Strain A: Conventional: 37% Gnotobiotic: 55%</td>
</tr>
<tr>
<td valign="top" align="left">Jones, <xref ref-type="bibr" rid="B46">1981</xref></td>
<td valign="top" align="center">60</td>
<td valign="top" align="center">8&#x02013;12</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="left">M/F</td>
<td valign="top" align="left">Yorkshire</td>
<td valign="top" align="left">10&#x02013;35 days</td>
<td valign="top" align="left">None</td>
<td valign="top" align="left"><italic>&#x003B2;-haemolytic Streptococci</italic> S85 (Group L)</td>
<td valign="top" align="left">10<sup>8</sup></td>
<td valign="top" align="center">10 ml</td>
<td valign="top" align="left">I.V.</td>
<td valign="top" align="left">T: Microbiology I: NRV</td>
<td valign="top" align="left">Acute</td>
<td valign="top" align="left">50%</td>
</tr>
<tr>
<td valign="top" align="left">Jones, <xref ref-type="bibr" rid="B47">1982</xref></td>
<td valign="top" align="center">23</td>
<td valign="top" align="center">8&#x02013;12</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="left">M/F</td>
<td valign="top" align="left">Yorkshire</td>
<td valign="top" align="left">18&#x02013;48 h</td>
<td valign="top" align="left">None</td>
<td valign="top" align="left"><italic>&#x003B2;-haemolytic Streptococci</italic> S85 (Group L)</td>
<td valign="top" align="left">10<sup>8</sup></td>
<td valign="top" align="center">10 ml</td>
<td valign="top" align="left">I.V.</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: NRV</td>
<td valign="top" align="left">Acute</td>
<td valign="top" align="left">60%</td>
</tr>
<tr>
<td valign="top" align="left">Johnson et al., <xref ref-type="bibr" rid="B44">1986</xref></td>
<td valign="top" align="center">41</td>
<td valign="top" align="center">3&#x02013;4</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="left">M/F</td>
<td valign="top" align="left">Crossbred</td>
<td valign="top" align="left">24 days</td>
<td valign="top" align="left">Catheter</td>
<td valign="top" align="left"><italic>&#x003B2;-haemolytic Streptococci</italic> (Group C)</td>
<td valign="top" align="left">1 &#x000D7; 10<sup>7</sup></td>
<td valign="top" align="center">NR</td>
<td valign="top" align="left">I.V.</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: NR</td>
<td valign="top" align="left">Acute</td>
<td valign="top" align="left">Catheter: 94% No catheter: 11%</td>
</tr>
<tr>
<td valign="top" align="left">Dewar et al., <xref ref-type="bibr" rid="B23">1987</xref></td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="center">25&#x02013;35</td>
<td valign="top" align="left">M</td>
<td valign="top" align="left">G&#x000F6;ttingen mini-pigs</td>
<td valign="top" align="left">20&#x02013;55 days</td>
<td valign="top" align="left">Catheter</td>
<td valign="top" align="left"><italic>S. sanguis</italic> NCTC7864</td>
<td valign="top" align="left">3 &#x000D7; 10<sup>8</sup></td>
<td valign="top" align="center">NR</td>
<td valign="top" align="left">I.V.</td>
<td valign="top" align="left">T: NR I: NR</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="left">75%</td>
</tr>
<tr>
<td valign="top" align="left">Christiansen et al., <xref ref-type="bibr" rid="B12">2013b</xref></td>
<td valign="top" align="center">14</td>
<td valign="top" align="center">6&#x02013;9</td>
<td valign="top" align="center">13&#x02013;25</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">Yorkshire-Landrace crossbred</td>
<td valign="top" align="left">1&#x02013;11 days</td>
<td valign="top" align="left">Catheter</td>
<td valign="top" align="left"><italic>S. aureus</italic> S54F9 and NCTC8325-4</td>
<td valign="top" align="left">10<sup>5</sup>&#x02013;10<sup>7</sup></td>
<td valign="top" align="center">13-25 ml</td>
<td valign="top" align="left">I.V.</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: NR</td>
<td valign="top" align="left">Acute</td>
<td valign="top" align="left">Both strains: 25% S54F9 10<sup>7</sup> CFU: 100%</td>
</tr>
<tr>
<td valign="top" align="left">Christiansen et al., <xref ref-type="bibr" rid="B11">2013a</xref></td>
<td valign="top" align="center">17</td>
<td valign="top" align="center">6&#x02013;10</td>
<td valign="top" align="center">13&#x02013;25</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">Yorkshire-Landrace crossbred</td>
<td valign="top" align="left">1&#x02013;11 days</td>
<td valign="top" align="left">Catheter</td>
<td valign="top" align="left"><italic>S. aureus</italic> S54F9 and NCTC8325-4</td>
<td valign="top" align="left">10<sup>5</sup>&#x02013;10<sup>8</sup></td>
<td valign="top" align="center">13-25 ml</td>
<td valign="top" align="left">I.V.</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: NR</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="left">Both strains: 22% S54F9 10<sup>7</sup> CFU: 100%</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN1">
<label>&#x0002A;</label>
<p><italic>The percentage of animals with infection. T, verification method in tissue; I, verification method on implant; CFU, colony forming units; NR, not registered; F, female; M, male; I.V, intravenous; S.C., sub cutaneous; NRV, not relevant</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s6">
<title>Porcine models of pyelonephritis</title>
<p>The kidneys of pigs are anatomically quite similar to those of humans as both have multirenculate and multipapillate kidneys. Another similarity between pigs and humans is the glomerular filtration rate (Ibrahim et al., <xref ref-type="bibr" rid="B33">2006</xref>). An important difference is related to the vascularity of the kidneys. In pigs the vascular plane is parted transversely and not longitudinally as in humans (Swindle et al., <xref ref-type="bibr" rid="B75">2012</xref>). The similarities have allowed the development of vesicourethral and intrarenal reflux models in pigs (Swindle and Smith, <xref ref-type="bibr" rid="B74">1998</xref>).</p>
<p>In humans, the chronic form of pyelonephritis is usually caused by urinary reflux and urethral obstruction (Damjanov and Linder, <xref ref-type="bibr" rid="B18">1996</xref>). The most common pathogens involved are <italic>Escherichia coli</italic> and <italic>Proteus</italic> sp. Pathologically, fibrotic scarring is present at the poles, due to urinary reflux as well as dilated calices. Histopathologically, interstitial fibrosis is seen along with mononuclear leukocyte infiltration and tubular atrophy (Damjanov and Linder, <xref ref-type="bibr" rid="B18">1996</xref>). The lesions are asymmetrical which results in an irregular contraction of the kidneys. In pigs, the lesions are similar to those in humans and the most common pathogen is also <italic>E. coli</italic> (Figure <xref ref-type="fig" rid="F3">3C1</xref>). However, other pathogens such as <italic>Staphylococcus, Streptococcus, Enterobacter, Proteus</italic>, and <italic>Actinobaculum</italic> have also been isolated from cases of porcine pyelonephritis (Maxie, <xref ref-type="bibr" rid="B55">2007</xref>).</p>
<p>Only a few porcine models of pyelonephritis have been created. A vesico-urethral reflux model was established in Sinclair mini-pigs for the study of chronic atrophic pyelonephritis (Table <xref ref-type="table" rid="T4">4</xref>; Hodson et al., <xref ref-type="bibr" rid="B32">1975</xref>). Both the inoculated and non-inoculated group developed scarring composed of fibrosis and leukocyte infiltration. Six of the inoculated pigs in the experiment eradicated the induced infection with <italic>E. coli</italic>, spontaneously, whereas 11 of the non-inoculated pigs, developed an infection (Hodson et al., <xref ref-type="bibr" rid="B32">1975</xref>). Ransley and Risdon (<xref ref-type="bibr" rid="B64">1981</xref>) also developed a vesico-urethral reflux model using <italic>E. coli</italic> (Table <xref ref-type="table" rid="T4">4</xref>). To sustain infection, the bacteria were inoculated within paraffin wax into the bladder. The aim of that study was to test different therapeutic methods for chronic pyelonephritis. The pigs developed marked interstitial renal fibrosis and were treated with different antibiotics without significant effect (Ransley and Risdon, <xref ref-type="bibr" rid="B64">1981</xref>). In another study by Farhat et al. (<xref ref-type="bibr" rid="B26">2002</xref>), <italic>E. coli</italic> was also embedded in paraffin wax in order to sustain the infection. In the model, a total of 67% of the pigs developed renal scarring (Table <xref ref-type="table" rid="T4">4</xref>; Farhat et al., <xref ref-type="bibr" rid="B26">2002</xref>). Finally, in a novel model of acute pyelonephritis, a catheter was placed directly into the renal pelvis for inoculation (Table <xref ref-type="table" rid="T4">4</xref>; Isling et al., <xref ref-type="bibr" rid="B34">2011</xref>). Three different strains of <italic>E. coli</italic> with different virulence factors were used for inoculation (Isling et al., <xref ref-type="bibr" rid="B34">2011</xref>). In the study, the strain which was positive for P fimbriae, an important virulence factor in the development of human pyelonephritis, developed the most pronounced lesions and mimicked the lesions seen in humans (Figures <xref ref-type="fig" rid="F3">3C2,C3</xref>; Isling et al., <xref ref-type="bibr" rid="B34">2011</xref>).</p>
<table-wrap position="float" id="T4">
<label>Table 4</label>
<caption><p>Porcine models of pyelonephritis.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>References (year)</bold></th>
<th valign="top" align="center" colspan="7" style="border-bottom: thin solid #000000;"><bold>Model design</bold></th>
<th valign="top" align="center" colspan="4" style="border-bottom: thin solid #000000;"><bold>Inoculum</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>Outcome</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="center"><bold>Number of animals</bold></th>
<th valign="top" align="center"><bold>Age (weeks)</bold></th>
<th valign="top" align="left"><bold>Weight (kg)</bold></th>
<th valign="top" align="left"><bold>Sex</bold></th>
<th valign="top" align="left"><bold>Breed</bold></th>
<th valign="top" align="left"><bold>Infection time</bold></th>
<th valign="top" align="left"><bold>Implant/modification</bold></th>
<th valign="top" align="left"><bold>Bacteria</bold></th>
<th valign="top" align="left"><bold>Dose CFU/ml</bold></th>
<th valign="top" align="center"><bold>Volume</bold></th>
<th valign="top" align="left"><bold>Route</bold></th>
<th valign="top" align="left"><bold>Bacterial verification T/I</bold></th>
<th valign="top" align="left"><bold>Infection stage</bold></th>
<th valign="top" align="left"><bold>Success rate<xref ref-type="table-fn" rid="TN2"><sup>&#x0002A;</sup></xref></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Hodson et al., <xref ref-type="bibr" rid="B32">1975</xref></td>
<td valign="top" align="center">35</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">Sinclair mini-pig</td>
<td valign="top" align="left">7&#x02013;130 days</td>
<td valign="top" align="left">Vesico-urethral reflux</td>
<td valign="top" align="left"><italic>E. coli</italic> 0111:B4</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="left">Intravesical</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: NRV</td>
<td valign="top" align="left">Acute &#x0002B; Chronic</td>
<td valign="top" align="left">64%</td>
</tr>
<tr>
<td valign="top" align="left">Ransley and Risdon, <xref ref-type="bibr" rid="B64">1981</xref></td>
<td valign="top" align="center">43</td>
<td valign="top" align="center">2-4</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="left">M/F</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="left">1&#x02013;4 weeks</td>
<td valign="top" align="left">Vesico-urethral reflux Paraffin wax</td>
<td valign="top" align="left"><italic>E. coli</italic> (strain NR)</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="center">5&#x02013;10 ml</td>
<td valign="top" align="left">Intravesical</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: NR</td>
<td valign="top" align="left">Chronic</td>
<td valign="top" align="left">Control: 33&#x02013;68% Gentamicin&#x0002B; Chloramphenicol: 11% Nitrofurantoin: 19%</td>
</tr>
<tr>
<td valign="top" align="left">Farhat et al., <xref ref-type="bibr" rid="B26">2002</xref></td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">3-4</td>
<td valign="top" align="left">10</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">Yorkshire</td>
<td valign="top" align="left">6&#x02013;8 weeks</td>
<td valign="top" align="left">Vesico-urethral reflux Paraffin wax</td>
<td valign="top" align="left"><italic>E. coli</italic> (strain NR)</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="left">Intravesical</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology &#x0002B; Ultrasound I: NR</td>
<td valign="top" align="left">Chronic</td>
<td valign="top" align="left">67%</td>
</tr>
<tr>
<td valign="top" align="left">Isling et al., <xref ref-type="bibr" rid="B34">2011</xref></td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="left">19</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">Yorkshire crossbred</td>
<td valign="top" align="left">6 h</td>
<td valign="top" align="left">Catheter</td>
<td valign="top" align="left"><italic>E. coli</italic> LK67, LK76 and LK82</td>
<td valign="top" align="left">10<sup>9</sup></td>
<td valign="top" align="center">3.25 ml &#x000D7; 3</td>
<td valign="top" align="left">In renal pelvis</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: NR</td>
<td valign="top" align="left">Acute</td>
<td valign="top" align="left">All strains: 88%</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN2">
<label>&#x0002A;</label>
<p><italic>xThe percentage of animals with infection. T, verification method in tissue; I, verification method on implant; CFU, colony forming units; NR, not registered; F, female; M, male; NRV, not relevant</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s7">
<title>Porcine models of hematogenous osteomyelitis</title>
<p>The rate of bone remodeling as well as the cross-sectional diameter of the femoral bone is similar in pigs and humans (Pearce et al., <xref ref-type="bibr" rid="B62">2007</xref>). Pigs also show similarities to human bone composition, especially with respect to mineral density and mineralization of the bones (Aerssens et al., <xref ref-type="bibr" rid="B1">1998</xref>). The muscles and bones of pigs are more massive compared to humans which reflects that they are quadruped (Swindle and Smith, <xref ref-type="bibr" rid="B74">1998</xref>). Although, pigs have a denser osseous trabecular network, the lamellar bone structure is similar to humans (Pearce et al., <xref ref-type="bibr" rid="B62">2007</xref>). Due to the similarities in bone composition and regeneration, the pig has been used as a model for several studies of both hematogenous and IAO (Wood et al., <xref ref-type="bibr" rid="B78">1971</xref>; Koschmieder et al., <xref ref-type="bibr" rid="B50">1975</xref>; Patterson et al., <xref ref-type="bibr" rid="B61">1993</xref>; Rink et al., <xref ref-type="bibr" rid="B66">2001</xref>; Jensen et al., <xref ref-type="bibr" rid="B37">2010b</xref>, <xref ref-type="bibr" rid="B38">2016</xref>,<xref ref-type="bibr" rid="B39">2017</xref>; Johansen et al., <xref ref-type="bibr" rid="B40">2010</xref>, <xref ref-type="bibr" rid="B41">2012a</xref>,<xref ref-type="bibr" rid="B43">b</xref>, <xref ref-type="bibr" rid="B42">2013</xref>; T&#x000F8;ttrup et al., <xref ref-type="bibr" rid="B76">2016</xref>).</p>
<p>In children, osteomyelitis is predominantly caused by hematogenous spread of bacteria. The lesions are most often located in long bones especially within the metaphysis of femur and tibia (Lew and Waldvogel, <xref ref-type="bibr" rid="B52">2004</xref>). In adults, the vertebral bones are most commonly infected (Lew and Waldvogel, <xref ref-type="bibr" rid="B52">2004</xref>; Brady et al., <xref ref-type="bibr" rid="B8">2008</xref>). Following infection, an abscess will be formed, with a fibrous layer surrounding leukocytes and bacteria (Damjanov and Linder, <xref ref-type="bibr" rid="B18">1996</xref>). The most common bacterium causing human osteomyelitis is <italic>S. aureus</italic>, but <italic>S. epidermidis</italic> is also often involved. Other bacteria involved in hematogenous osteomyelitis are <italic>Streptococcus, Pneumococcus, E. coli, Klebsiella, Salmonella</italic>, and <italic>Bacteroides</italic> (Damjanov and Linder, <xref ref-type="bibr" rid="B18">1996</xref>). In slaughter pigs, the dominant site of infection is also within the metaphysis of long bones and the vertebrae (Figure <xref ref-type="fig" rid="F3">3D1</xref>). In pigs, hematogenous osteomyelitis is often caused by <italic>T. pyogenes</italic>, but <italic>S. aureus</italic> may also be the cause (Zachary, <xref ref-type="bibr" rid="B80">2017</xref>). Although the same histomorphology is present, there will often be multifocal lesions in pigs (Maxie, <xref ref-type="bibr" rid="B55">2007</xref>). In conventional pigs, the portal of entrance is often tail bites causing pyemia (B&#x000E6;kbo et al., <xref ref-type="bibr" rid="B4">2016</xref>).</p>
<p>Several porcine models of hematogenous osteomyelitis have been developed. The first was established in 1971 by Wood et al. In that study, two different strains of <italic>S. pyogenes</italic> were inoculated through vena cava cranialis and they were inoculated once a day for three consecutive days (Table <xref ref-type="table" rid="T5">5</xref>; Wood et al., <xref ref-type="bibr" rid="B78">1971</xref>). The pigs developed endocarditis, arthritis and osteomyelitis. Some of the osteomyelitis lesions were caused by extension of the arthritis lesions and some were due to a direct hematogenous spread (Wood et al., <xref ref-type="bibr" rid="B78">1971</xref>). In another study, pigs were inoculated intravenously with <italic>S. aureus</italic> and they developed microscopic metaphyseal osteomyelitis lesions after 12 h (Table <xref ref-type="table" rid="T5">5</xref>; Jensen et al., <xref ref-type="bibr" rid="B37">2010b</xref>). In a study by Johansen et al. (<xref ref-type="bibr" rid="B40">2010</xref>), <italic>S. aureus</italic> was inoculated into the brachial artery, in order to induce osteomyelitis in the distal part of the forelimb (Table <xref ref-type="table" rid="T5">5</xref>; Johansen et al., <xref ref-type="bibr" rid="B40">2010</xref>). It was found that the minimum required dose for inoculation was 5 &#x000D7; 10<sup>3</sup> CFU/ml, in order to induce suppurative bone lesions (Johansen et al., <xref ref-type="bibr" rid="B40">2010</xref>). In three other studies by Johansen et al. (<xref ref-type="bibr" rid="B41">2012a</xref>,<xref ref-type="bibr" rid="B43">b</xref>, <xref ref-type="bibr" rid="B42">2013</xref>), <italic>S. aureus</italic> was inoculated into the femoral artery (Table <xref ref-type="table" rid="T5">5</xref>; Johansen et al., <xref ref-type="bibr" rid="B41">2012a</xref>,<xref ref-type="bibr" rid="B43">b</xref>, <xref ref-type="bibr" rid="B42">2013</xref>). In the first study, three different strains of <italic>S. aureus</italic> were examined. The porcine strain, S54F9, resulted in the development of osteomyelitis lesions in all pigs. It was also shown that biofilm was present in the infected bone by PNA FISH (Johansen et al., <xref ref-type="bibr" rid="B41">2012a</xref>). The novel technique of intraarterial inoculation used for inducing experimental osteomyelitis, was detailed in the second study by Johansen et al. (<xref ref-type="bibr" rid="B43">2012b</xref>; Figures <xref ref-type="fig" rid="F3">3D2,D3</xref>). In the third study from 2013, surgical debridement of experimental osteomyelitis was performed, and the lesions seen in the pigs were comparable to osteomyelitis lesions in kids. This study showed that the pig is a good model for evaluating surgical treatment methods for hematogenous osteomyelitis (Johansen et al., <xref ref-type="bibr" rid="B42">2013</xref>).</p>
<table-wrap position="float" id="T5">
<label>Table 5</label>
<caption><p>Porcine models of hematogenous osteomyelitis.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>References (year)</bold></th>
<th valign="top" align="center" colspan="7" style="border-bottom: thin solid #000000;"><bold>Model design</bold></th>
<th valign="top" align="center" colspan="4" style="border-bottom: thin solid #000000;"><bold>Inoculum</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>Outcome</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="center"><bold>Number of animals</bold></th>
<th valign="top" align="center"><bold>Age (weeks)</bold></th>
<th valign="top" align="center"><bold>Weight (kg)</bold></th>
<th valign="top" align="left"><bold>Sex</bold></th>
<th valign="top" align="left"><bold>Breed</bold></th>
<th valign="top" align="left"><bold>Infection time</bold></th>
<th valign="top" align="left"><bold>Implant/modification</bold></th>
<th valign="top" align="left"><bold>Bacteria</bold></th>
<th valign="top" align="left"><bold>Dose CFU/ml</bold></th>
<th valign="top" align="center"><bold>Volume</bold></th>
<th valign="top" align="left"><bold>Route</bold></th>
<th valign="top" align="left"><bold>Bacterial verification T/I</bold></th>
<th valign="top" align="left"><bold>Infection stage</bold></th>
<th valign="top" align="left"><bold>Success rate<xref ref-type="table-fn" rid="TN3"><sup>&#x0002A;</sup></xref></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Wood et al., <xref ref-type="bibr" rid="B78">1971</xref></td>
<td valign="top" align="center">18</td>
<td valign="top" align="center">10&#x02013;12</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="left">M/F</td>
<td valign="top" align="left">Crossbred</td>
<td valign="top" align="left">58&#x02013;63 days</td>
<td valign="top" align="left">None</td>
<td valign="top" align="left"><italic>S. pyogenes</italic> Strain Richards (type 3) and strain 25 (type 25)</td>
<td valign="top" align="left">Richards: 6.39 &#x000D7; 10<sup>8</sup> Strain 25: 1.55 &#x000D7; 10<sup>8</sup></td>
<td valign="top" align="center">3 ml</td>
<td valign="top" align="left">I.V.</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: NRV</td>
<td valign="top" align="left">Chronic</td>
<td valign="top" align="left">Both strains: 83%</td>
</tr>
<tr>
<td valign="top" align="left">Jensen et al., <xref ref-type="bibr" rid="B37">2010b</xref></td>
<td valign="top" align="center">16</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">20-25</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">Yorkshire-Landrace crossbred</td>
<td valign="top" align="left">6&#x02013;48 h</td>
<td valign="top" align="left">None</td>
<td valign="top" align="left"><italic>S. aureus</italic> Strain S54F9</td>
<td valign="top" align="left">1 &#x000D7; 10<sup>8</sup></td>
<td valign="top" align="center">1 ml/kg (1&#x02013;2x)</td>
<td valign="top" align="left">I.V.</td>
<td valign="top" align="left">T: Histology I: NRV</td>
<td valign="top" align="left">Acute</td>
<td valign="top" align="left">75%</td>
</tr>
<tr>
<td valign="top" align="left">Johansen et al., <xref ref-type="bibr" rid="B40">2010</xref></td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">8&#x02013;9</td>
<td valign="top" align="center">15</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">Yorkshire-Landrace crossbred</td>
<td valign="top" align="left">5&#x02013;15 days</td>
<td valign="top" align="left">None</td>
<td valign="top" align="left"><italic>S. aureus</italic> Strain S54F9</td>
<td valign="top" align="left">5.50, 500, 5 &#x000D7; 10<sup>3</sup> or 5 &#x000D7; 10<sup>4</sup></td>
<td valign="top" align="center">0.5 ml</td>
<td valign="top" align="left">I.A.</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: NRV</td>
<td valign="top" align="left">Acute</td>
<td valign="top" align="left">5 &#x000D7; 10<sup>3</sup> CFU: 50% 5 &#x000D7; 10<sup>4</sup> CFU: 100%</td>
</tr>
<tr>
<td valign="top" align="left">Johansen et al., <xref ref-type="bibr" rid="B41">2012a</xref></td>
<td valign="top" align="center">11</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">30</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">Yorkshire-Landrace crossbred</td>
<td valign="top" align="left">11&#x02013;15 days</td>
<td valign="top" align="left">None</td>
<td valign="top" align="left"><italic>S. aureus</italic> Strain S54F9, NCTC-8325-4 and UAMS-1</td>
<td valign="top" align="left">10<sup>4</sup></td>
<td valign="top" align="center">1 ml</td>
<td valign="top" align="left">I.A.</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology (PNA FISH) I: NRV</td>
<td valign="top" align="left">Chronic</td>
<td valign="top" align="left">All strains: 44% S54F9: 100%</td>
</tr>
<tr>
<td valign="top" align="left">Johansen et al., <xref ref-type="bibr" rid="B43">2012b</xref></td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">30</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="left">11&#x02013;15 days</td>
<td valign="top" align="left">None</td>
<td valign="top" align="left"><italic>S. aureus</italic> Strain S54F9</td>
<td valign="top" align="left">10<sup>4</sup></td>
<td valign="top" align="center">1 ml</td>
<td valign="top" align="left">I.A.</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: NRV</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="left">100%</td>
</tr>
<tr>
<td valign="top" align="left">Johansen et al., <xref ref-type="bibr" rid="B42">2013</xref></td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">30</td>
<td valign="top" align="left">M/F</td>
<td valign="top" align="left">Yorkshire-Landrace crossbred</td>
<td valign="top" align="left">6&#x02013;8 days</td>
<td valign="top" align="left">None</td>
<td valign="top" align="left"><italic>S. aureus</italic> Strain S54F9</td>
<td valign="top" align="left">5 &#x000D7; 10<sup>5</sup> and 5 &#x000D7; 10<sup>6</sup></td>
<td valign="top" align="center">1 ml</td>
<td valign="top" align="left">I.A.</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: NRV</td>
<td valign="top" align="left">Chronic</td>
<td valign="top" align="left">100%</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN3">
<label>&#x0002A;</label>
<p><italic>The percentage of animals with infection. T, verification method in tissue; I, verification method on implant; CFU, colony forming units; NR, not registered; F, female; M, male; I.V., intravenous; I.A., intraarterial; NRV, not relevant</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s8">
<title>Porcine models of implant-associated osteomyelitis</title>
<p>IAO is generally split into three groups depending on infection time following insertion of the implant, i.e., early, delayed, and late (Zimmerli et al., <xref ref-type="bibr" rid="B81">2004</xref>). In humans, the most common type of infection is in the delayed group (3&#x02013;24 months after surgery) and it is caused by local contamination by <italic>S. aureus</italic> or other bacteria during insertion of the implant (Figure <xref ref-type="fig" rid="F3">3E1</xref>; Zimmerli et al., <xref ref-type="bibr" rid="B81">2004</xref>). The late type is caused by a hematogenous spread of bacteria colonizing the implant/prosthesis up to several years after insertion (Zimmerli et al., <xref ref-type="bibr" rid="B81">2004</xref>). Histologically, a periprosthetic membrane surrounding the implant will be formed. This membrane can be divided into four different types (I&#x02013;IV), where &#x0201C;Type II&#x0201D; is the infectious type. The infectious type is characterized by the proliferation of fibroblasts and small blood vessels, edema, and leukocyte infiltration, dominated by PMNs (Morawietz et al., <xref ref-type="bibr" rid="B58">2006</xref>). Although, IAO does not occur spontaneously in pigs, it is assumed, that the pig will be a good model, due to its similarity in bone composition and remodeling (Pearce et al., <xref ref-type="bibr" rid="B62">2007</xref>).</p>
<p>In a porcine model by Koschmieder et al. (<xref ref-type="bibr" rid="B50">1975</xref>), the effect of Gentamicin embedded in Palacos bone cement was examined (Koschmieder et al., <xref ref-type="bibr" rid="B50">1975</xref>). In the study, IAO was established by traumatic intramedullary inoculation of <italic>S. aureus</italic> (Table <xref ref-type="table" rid="T5">5</xref>), however, bacterial contamination was found and limited the conclusions of the study (Koschmieder et al., <xref ref-type="bibr" rid="B50">1975</xref>). A traumatic mandibular IAO model was established in pigs using an 8 mm trephine (Table <xref ref-type="table" rid="T5">5</xref>). In the model, three strains of <italic>S. aureus</italic> were inoculated intramedullary and afterwards, the trephine hole was filled with either bone cement or wax (Patterson et al., <xref ref-type="bibr" rid="B61">1993</xref>). Another porcine IAO model was established by Rink et al. (<xref ref-type="bibr" rid="B66">2001</xref>) where an 18G needle was inserted in a mid-diaphysis fracture line and <italic>S. aureus</italic> was inoculated (Table <xref ref-type="table" rid="T6">6</xref>). This was done in order to make a cDNA library of the cellular immune response in a porcine model of IAO (Rink et al., <xref ref-type="bibr" rid="B66">2001</xref>) Recently, a novel porcine model of IAO was developed and comprehensively analyzed according to the local, regional and systemic response. In this model, a small Kirschner wire was inserted into the right tibial bone. Before the implant insertion, three different doses of <italic>S. aureus</italic> were applied (Table <xref ref-type="table" rid="T6">6</xref>), and the model showed good reproducibility when an inoculum dose of 10<sup>4</sup> CFU/ml was used (Figures <xref ref-type="fig" rid="F3">3E2,E3</xref>; Jensen et al., <xref ref-type="bibr" rid="B39">2017</xref>). In a later study by Jensen et al. (<xref ref-type="bibr" rid="B38">2016</xref>), the former porcine IAO model was used to examine the extension of infection into the peri-implanted bone tissue after 5 days (Table <xref ref-type="table" rid="T6">6</xref>; Jensen et al., <xref ref-type="bibr" rid="B38">2016</xref>). Recently, a study performed by T&#x000F8;ttrup et al. (<xref ref-type="bibr" rid="B76">2016</xref>), focused on the penetration of cefuroxime into the infected bone lesions also using the porcine IAO model (Table <xref ref-type="table" rid="T6">6</xref>; T&#x000F8;ttrup et al., <xref ref-type="bibr" rid="B76">2016</xref>). The models of IAO mentioned above were all established successfully, and showed advantages for analyzing the bioavailability of antibiotics in e.g., bone cement or given systemically and the impact of the immune system. Moreover, as it also is the situation in human clinical settings, one should be aware of contamination problems when inserting implants.</p>
<table-wrap position="float" id="T6">
<label>Table 6</label>
<caption><p>Porcine models of implant-associated osteomyelitis.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>References (year)</bold></th>
<th valign="top" align="center" colspan="7" style="border-bottom: thin solid #000000;"><bold>Model design</bold></th>
<th valign="top" align="center" colspan="4" style="border-bottom: thin solid #000000;"><bold>Inoculum</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>Outcome</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="center"><bold>Number of animals</bold></th>
<th valign="top" align="center"><bold>Age (weeks)</bold></th>
<th valign="top" align="center"><bold>Weight (kg)</bold></th>
<th valign="top" align="left"><bold>Sex</bold></th>
<th valign="top" align="left"><bold>Breed</bold></th>
<th valign="top" align="left"><bold>Infection time</bold></th>
<th valign="top" align="left"><bold>Implant/modification</bold></th>
<th valign="top" align="center"><bold>Bacteria</bold></th>
<th valign="top" align="left"><bold>Dose CFU/ml</bold></th>
<th valign="top" align="left"><bold>Volume</bold></th>
<th valign="top" align="left"><bold>Route</bold></th>
<th valign="top" align="left"><bold>Bacterial verification T/I</bold></th>
<th valign="top" align="left"><bold>Infection stage</bold></th>
<th valign="top" align="left"><bold>Success rate<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Koschmieder et al., <xref ref-type="bibr" rid="B50">1975</xref></td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="left">Domestic landrace</td>
<td valign="top" align="left">16 days</td>
<td valign="top" align="left">Traumatic Bone cement</td>
<td valign="top" align="center"><italic>S. aureus haemolyticus</italic> (Strain NR)</td>
<td valign="top" align="left">2 &#x000D7; 10<sup>8</sup></td>
<td valign="top" align="left">2 ml</td>
<td valign="top" align="left">Traumatic</td>
<td valign="top" align="left">T: Microbiology I: NR</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="left">NR</td>
</tr>
<tr>
<td valign="top" align="left">Patterson et al., <xref ref-type="bibr" rid="B61">1993</xref></td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">104&#x02013;260</td>
<td valign="top" align="center">68&#x02013;95</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">Yucatan mini-pigs</td>
<td valign="top" align="left">12 weeks</td>
<td valign="top" align="left">Traumatic Bone cement or bone wax</td>
<td valign="top" align="center"><italic>S. aureus</italic> ATCC strains 6538P, 25923, and 29213</td>
<td valign="top" align="left">10<sup>8</sup>&#x02013;10<sup>9</sup></td>
<td valign="top" align="left">1 ml</td>
<td valign="top" align="left">Traumatic</td>
<td valign="top" align="left">T: Microbiology I: NR</td>
<td valign="top" align="left">Chronic</td>
<td valign="top" align="left">All strains: 100%</td>
</tr>
<tr>
<td valign="top" align="left">Rink et al., <xref ref-type="bibr" rid="B66">2001</xref></td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="center">50-65</td>
<td valign="top" align="left">M</td>
<td valign="top" align="left">Yorkshire-Pietrain crossbred</td>
<td valign="top" align="left">28 days</td>
<td valign="top" align="left">18G needle</td>
<td valign="top" align="center"><italic>S. aureus</italic></td>
<td valign="top" align="left">1.2 &#x000D7; 10<sup>3</sup></td>
<td valign="top" align="left">NA</td>
<td valign="top" align="left">Traumatic</td>
<td valign="top" align="left">T: Radiography I: NR</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="left">NR</td>
</tr>
<tr>
<td valign="top" align="left">Jensen et al., <xref ref-type="bibr" rid="B39">2017</xref></td>
<td valign="top" align="center">42</td>
<td valign="top" align="center">12 and 32</td>
<td valign="top" align="center">30 and 60&#x02013;67</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">Danish landrace</td>
<td valign="top" align="left">5 days</td>
<td valign="top" align="left">Kirschner wire</td>
<td valign="top" align="center"><italic>S. aureus</italic> Strain S54F9 spa-type t1333</td>
<td valign="top" align="left">10<sup>2</sup>&#x02013;10<sup>4</sup></td>
<td valign="top" align="left">10 &#x003BC;l</td>
<td valign="top" align="left">Traumatic</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: PNA FISH</td>
<td valign="top" align="left">Chronic</td>
<td valign="top" align="left">33- 83%</td>
</tr>
<tr>
<td valign="top" align="left">Jensen et al., <xref ref-type="bibr" rid="B38">2016</xref></td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="center">30</td>
<td valign="top" align="left">M/F</td>
<td valign="top" align="left">NR</td>
<td valign="top" align="left">2&#x02013;6 days</td>
<td valign="top" align="left">Kirschner wire</td>
<td valign="top" align="center"><italic>S. aureus</italic> Strain S54F9 spa-type t1333</td>
<td valign="top" align="left">10<sup>4</sup></td>
<td valign="top" align="left">10 &#x003BC;l</td>
<td valign="top" align="left">Traumatic</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: PNA FISH &#x0002B; SEM</td>
<td valign="top" align="left">Acute &#x0002B; Chronic</td>
<td valign="top" align="left">67%</td>
</tr>
<tr>
<td valign="top" align="left">T&#x000F8;ttrup et al., <xref ref-type="bibr" rid="B76">2016</xref></td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">NR</td>
<td valign="top" align="center">67&#x02013;77</td>
<td valign="top" align="left">F</td>
<td valign="top" align="left">Danish landrace</td>
<td valign="top" align="left">5 days</td>
<td valign="top" align="left">Kirschner wire</td>
<td valign="top" align="center"><italic>S. aureus</italic> Strain S54F9 spa-type t1333</td>
<td valign="top" align="left">10<sup>4</sup></td>
<td valign="top" align="left">10 &#x003BC;l</td>
<td valign="top" align="left">Traumatic</td>
<td valign="top" align="left">T: Microbiology &#x0002B; Histology I: NR</td>
<td valign="top" align="left">Acute</td>
<td valign="top" align="left">100%</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN4">
<label>&#x0002A;</label>
<p><italic>The percentage of animals with infection. T, verification method in tissue; I, verification method on implant; CFU, colony forming units; NR, not registered; F, female; M, male</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s9">
<title>Summary</title>
<p>The basic knowledge of infectious biofilm has been achieved from <italic>in vitro</italic> studies (Lebeaux et al., <xref ref-type="bibr" rid="B51">2013</xref>). However, biofilm grown <italic>in vitro</italic> is not in every respect comparable to biofilm produced <italic>in vivo</italic> (Bjarnsholt et al., <xref ref-type="bibr" rid="B6">2013</xref>). Therefore, it is advantageous to perform studies of infectious biofilm using <italic>in vivo</italic> experiment, as this will allow studies of the host response with regard to the mechanisms of formation, immune response and therapeutically (Coenye and Nelis, <xref ref-type="bibr" rid="B13">2010</xref>; Lebeaux et al., <xref ref-type="bibr" rid="B51">2013</xref>; Stewart, <xref ref-type="bibr" rid="B72">2014</xref>).</p>
<p>The pig has proven to be an appropriate animal model for the study of chronic bacterial biofilm diseases (Sullivan et al., <xref ref-type="bibr" rid="B73">2001</xref>). The pig allows for several therapeutical trials and also shares a number of similarities to humans with respect to anatomy and the immune system (Swindle and Smith, <xref ref-type="bibr" rid="B74">1998</xref>; Dawson, <xref ref-type="bibr" rid="B22">2011</xref>; Meurens et al., <xref ref-type="bibr" rid="B57">2012</xref>; Swindle et al., <xref ref-type="bibr" rid="B75">2012</xref>). Although the present review highlights the many advantages of using pigs for modeling of human bacterial infectious diseases, small animal models are still used more extensively for the same purposes (Reizner et al., <xref ref-type="bibr" rid="B65">2014</xref>). Common reported advantages of small animal models are related to cost, housing, and handling (Reizner et al., <xref ref-type="bibr" rid="B65">2014</xref>). However, when applying an animal model one of the most important issues should be that the model is discriminative for the disease seen in humans. Due to the general increase in the use of pigs as experimental animals and an increased awareness of reliability in animal models, more porcine models of human bacterial infections are expected to be developed in the future.</p>
<p>Another important factor, which makes the pig a preferable model for many chronic infectious diseases, is that pigs develop many of the diseases spontaneously (Anderson, <xref ref-type="bibr" rid="B2">1976</xref>; Damjanov and Linder, <xref ref-type="bibr" rid="B18">1996</xref>; Maxie, <xref ref-type="bibr" rid="B55">2007</xref>; Jensen, <xref ref-type="bibr" rid="B35">2009</xref>; Jensen et al., <xref ref-type="bibr" rid="B36">2010a</xref>). The pathogenesis and lesions of spontaneously occurring chronic pressure wounds, endocarditis, pyelonephritis, and hematogenous osteomyelitis are similar to those seen in humans and are also often caused by the same bacteria (Anderson, <xref ref-type="bibr" rid="B2">1976</xref>; Damjanov and Linder, <xref ref-type="bibr" rid="B18">1996</xref>; Maxie, <xref ref-type="bibr" rid="B55">2007</xref>; Jensen, <xref ref-type="bibr" rid="B35">2009</xref>; Jensen et al., <xref ref-type="bibr" rid="B36">2010a</xref>). Although IAO does not occur naturally in pigs, porcine models have proven useful as a model because the induced lesions show great similarities to those of humans (Jensen et al., <xref ref-type="bibr" rid="B39">2017</xref>).</p>
<p>When developing a chronic bacterial infectious animal model, it is important to validate whether or not biofilm is formed. Biofilm can be formed both in tissue and on implants, therefore, in future studies it is important to analyze both (Donlan and Costerton, <xref ref-type="bibr" rid="B24">2002</xref>). Biofilm is an important factor in sustaining chronic infections in humans (Donlan and Costerton, <xref ref-type="bibr" rid="B24">2002</xref>; Costerton et al., <xref ref-type="bibr" rid="B16">2003</xref>; Burm&#x000F8;lle et al., <xref ref-type="bibr" rid="B10">2010</xref>). The ability of bacteria to form biofilm in porcine models has been demonstrated in a number of studies (Davis et al., <xref ref-type="bibr" rid="B21">2007</xref>, <xref ref-type="bibr" rid="B20">2013</xref>; Johansen et al., <xref ref-type="bibr" rid="B41">2012a</xref>; Roche et al., <xref ref-type="bibr" rid="B68">2012</xref>; Jensen et al., <xref ref-type="bibr" rid="B38">2016</xref>). However, when looking at the studies in this review (Tables <xref ref-type="table" rid="T2">2</xref>&#x02013;<xref ref-type="table" rid="T6">6</xref>), only five out of the thirty studies, actually commend on the formation of biofilm (Davis et al., <xref ref-type="bibr" rid="B21">2007</xref>, <xref ref-type="bibr" rid="B20">2013</xref>; Johansen et al., <xref ref-type="bibr" rid="B41">2012a</xref>; Roche et al., <xref ref-type="bibr" rid="B68">2012</xref>; Jensen et al., <xref ref-type="bibr" rid="B38">2016</xref>). This probably reflects that most of the studies were carried out decades ago and biofilm is a new focus of interest in regard to chronic infectious diseases. This may also be the reason why biofilm is usually not mentioned in chronic, spontaneous porcine infections (Maxie, <xref ref-type="bibr" rid="B55">2007</xref>). However, as seen from the descriptions of infections in the present review (Figure <xref ref-type="fig" rid="F3">3</xref>) it is likely that all chronic porcine infections are the cause of biofilm formation as in humans (Donlan and Costerton, <xref ref-type="bibr" rid="B24">2002</xref>; Costerton et al., <xref ref-type="bibr" rid="B16">2003</xref>; Brady et al., <xref ref-type="bibr" rid="B8">2008</xref>). This assumption has also been supported in porcine pneumonia due to <italic>Actinobacillus pleuropnumoniae</italic> (Tremblay et al., <xref ref-type="bibr" rid="B77">2017</xref>).</p>
<p>In the future, more models of chronic bacterial biofilm infections should be examined in pigs. Among others, studies of cystic fibrosis and otitis media based on porcine models would be relevant, as the pig has proven to have great similarity to humans with respect to anatomy of the respiratory tract and the conformation of the middle and inner ear (Pracy et al., <xref ref-type="bibr" rid="B63">1998</xref>; Meurens et al., <xref ref-type="bibr" rid="B57">2012</xref>; Schomberg et al., <xref ref-type="bibr" rid="B70">2016</xref>).</p>
</sec>
<sec id="s10">
<title>Author contributions</title>
<p>LJ and HJ designed the structure of the review. AJ collected all the references. LJ, AJ, and HJ drafted the manuscript.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack><p>Kristiane Barrington, Johanna Christensen, Klaus Kirketerp-M&#x000F8;ller, Louise Krag Isling, and Thomas Bjarnsholt are acknowledged for donation of pictures.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aerssens</surname> <given-names>J.</given-names></name> <name><surname>Boonen</surname> <given-names>S.</given-names></name> <name><surname>Lowet</surname> <given-names>G.</given-names></name> <name><surname>Dequeker</surname> <given-names>J.</given-names></name></person-group> (<year>1998</year>). <article-title>Interspecies differences in bone composition, density, and quality: potential implications for <italic>in vivo</italic> bone research</article-title>. <source>Endocrinology</source> <volume>139</volume>, <fpage>663</fpage>&#x02013;<lpage>670</lpage>. <pub-id pub-id-type="pmid">9449639</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>J. R.</given-names></name></person-group> (<year>1976</year>). <source>Muir&#x00027;s Textbook of Pathology, 10th Edn</source>. <publisher-loc>Great Britain</publisher-loc>: <publisher-name>Edward Arnold</publisher-name>.</citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Archer</surname> <given-names>N. K.</given-names></name> <name><surname>Mazaitis</surname> <given-names>M. J.</given-names></name> <name><surname>Costerton</surname> <given-names>J. W.</given-names></name> <name><surname>Leid</surname> <given-names>J. G.</given-names></name> <name><surname>Powers</surname> <given-names>M. E.</given-names></name> <name><surname>Shirtliff</surname> <given-names>M. E.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Staphylococcus aureus</italic> biofilms: properties, regulation and roles in human disease</article-title>. <source>Virulence</source> <volume>2</volume>, <fpage>445</fpage>&#x02013;<lpage>459</lpage>. <pub-id pub-id-type="doi">10.4161/viru.2.5.17724</pub-id><pub-id pub-id-type="pmid">21921685</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>B&#x000E6;kbo</surname> <given-names>A. K.</given-names></name> <name><surname>Petersen</surname> <given-names>J. V.</given-names></name> <name><surname>Larsen</surname> <given-names>M. H.</given-names></name> <name><surname>Alban</surname> <given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>The food safety value of de-boning finishing pig carcasses with lesions indicative of prior septicaemia</article-title>. <source>Food Control</source> <volume>69</volume>, <fpage>177</fpage>&#x02013;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodcont.2016.04.030</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bjarnsholt</surname> <given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of bacterial biofilms in chronic infections</article-title>. <source>APMIS</source> <volume>121</volume>, <fpage>1</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1111/apm.12099</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bjarnsholt</surname> <given-names>T.</given-names></name> <name><surname>Alhede</surname> <given-names>M.</given-names></name> <name><surname>Alhede</surname> <given-names>M.</given-names></name> <name><surname>Eickhardt-S&#x000F8;rensen</surname> <given-names>S. R.</given-names></name> <name><surname>Moser</surname> <given-names>C.</given-names></name> <name><surname>K&#x000FC;hl</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>The <italic>in vivo</italic> biofilm</article-title>. <source>Trends Microbiol.</source> <volume>21</volume>, <fpage>466</fpage>&#x02013;<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2013.06.002</pub-id><pub-id pub-id-type="pmid">23827084</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowler</surname> <given-names>P. G.</given-names></name></person-group> (<year>2002</year>). <article-title>Wound pathophysiology, infection and therapeutic options</article-title>. <source>Ann. Med.</source> <volume>34</volume>, <fpage>419</fpage>&#x02013;<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1080/078538902321012360</pub-id><pub-id pub-id-type="pmid">12523497</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brady</surname> <given-names>R. A.</given-names></name> <name><surname>Leid</surname> <given-names>J. G.</given-names></name> <name><surname>Calhoun</surname> <given-names>J. H.</given-names></name> <name><surname>Costerton</surname> <given-names>J. W.</given-names></name> <name><surname>Shirtliff</surname> <given-names>M. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Osteomyelitis and the role of biofilms in chronic infection</article-title>. <source>FEMS Immunol. Med. Microbiol.</source> <volume>52</volume>, <fpage>13</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-695X.2007.00357.x</pub-id><pub-id pub-id-type="pmid">18081847</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breuing</surname> <given-names>K.</given-names></name> <name><surname>Kaplan</surname> <given-names>S.</given-names></name> <name><surname>Liu</surname> <given-names>P.</given-names></name> <name><surname>Onderdonk</surname> <given-names>A. B.</given-names></name> <name><surname>Eriksson</surname> <given-names>E.</given-names></name></person-group> (<year>2003</year>). <article-title>Wound fluid bacterial levels exceed tissue bacterial counts in controlled porcine partial-thickness burn infections</article-title>. <source>Plast. Reconstr. Surg.</source> <volume>111</volume>, <fpage>781</fpage>&#x02013;<lpage>788</lpage>. <pub-id pub-id-type="doi">10.1097/01.PRS.0000041540.22057.89</pub-id><pub-id pub-id-type="pmid">12560699</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burm&#x000F8;lle</surname> <given-names>M.</given-names></name> <name><surname>Thomsen</surname> <given-names>T. R.</given-names></name> <name><surname>Fazli</surname> <given-names>M.</given-names></name> <name><surname>Dige</surname> <given-names>I.</given-names></name> <name><surname>Christensen</surname> <given-names>I. L.</given-names></name> <name><surname>Hom&#x000F8;e</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Biofilms in chronic infections - A matter of opportunity - Monospecies biofilms in multispecies infections</article-title>. <source>FEMS Immunol. Med. Microbiol.</source> <volume>59</volume>, <fpage>324</fpage>&#x02013;<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-695X.2010.00714.x</pub-id><pub-id pub-id-type="pmid">20602635</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christiansen</surname> <given-names>J. G.</given-names></name> <name><surname>Jensen</surname> <given-names>H. E.</given-names></name> <name><surname>Jensen</surname> <given-names>L. K.</given-names></name> <name><surname>Koch</surname> <given-names>J.</given-names></name> <name><surname>Aalb&#x000E6;k</surname> <given-names>B.</given-names></name> <name><surname>Nielsen</surname> <given-names>O. L.</given-names></name> <etal/></person-group>. (<year>2013a</year>). <article-title>Systemic inflammatory response and local cytokine expression in porcine models of endocarditis</article-title>. <source>APMIS</source> <volume>122</volume>, <fpage>292</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1111/apm.12145</pub-id><pub-id pub-id-type="pmid">23879680</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christiansen</surname> <given-names>J. G.</given-names></name> <name><surname>Jensen</surname> <given-names>H. E.</given-names></name> <name><surname>Johansen</surname> <given-names>L. K.</given-names></name> <name><surname>Koch</surname> <given-names>J.</given-names></name> <name><surname>Koch</surname> <given-names>J.</given-names></name> <name><surname>Aalbaek</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2013b</year>). <article-title>Porcine models of non-bacterial thrombotic endocarditis (NBTE) and infective endocarditis (IE) caused by <italic>Staphylococcus aureus</italic>: a preliminary study</article-title>. <source>J. Heart Valve Dis.</source> <volume>22</volume>, <fpage>368</fpage>&#x02013;<lpage>376</lpage>. <pub-id pub-id-type="pmid">24151763</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coenye</surname> <given-names>T.</given-names></name> <name><surname>Nelis</surname> <given-names>H. J.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>In vitro</italic> and <italic>in vivo</italic> model systems to study microbial biofilm formation</article-title>. <source>J. Microbiol. Methods</source> <volume>83</volume>, <fpage>89</fpage>&#x02013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.mimet.2010.08.018</pub-id><pub-id pub-id-type="pmid">20816706</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Costerton</surname> <given-names>J. W.</given-names></name> <name><surname>Lewandowski</surname> <given-names>Z.</given-names></name> <name><surname>Caldwell</surname> <given-names>D. E.</given-names></name> <name><surname>Korber</surname> <given-names>D. R.</given-names></name> <name><surname>Lappin-scott</surname> <given-names>H. M.</given-names></name></person-group> (<year>1995</year>). <article-title>Microbial biofilms</article-title>. <source>Annu. Rev. Microbiol.</source> <volume>49</volume>, <fpage>711</fpage>&#x02013;<lpage>745</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.mi.49.100195.003431</pub-id><pub-id pub-id-type="pmid">8561477</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Costerton</surname> <given-names>J. W.</given-names></name> <name><surname>Stewart</surname> <given-names>P.</given-names></name> <name><surname>Greenberg</surname> <given-names>E. P.</given-names></name></person-group> (<year>1999</year>). <article-title>Bacterial biofilms: a common cause of persistent infections</article-title>. <source>Science</source> <volume>284</volume>, <fpage>1318</fpage>&#x02013;<lpage>1322</lpage>. <pub-id pub-id-type="doi">10.1126/science.284.5418.1318</pub-id><pub-id pub-id-type="pmid">10334980</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Costerton</surname> <given-names>W.</given-names></name> <name><surname>Veeh</surname> <given-names>R.</given-names></name> <name><surname>Shirtliff</surname> <given-names>M.</given-names></name> <name><surname>Pasmore</surname> <given-names>M.</given-names></name> <name><surname>Post</surname> <given-names>C.</given-names></name> <name><surname>Ehrlich</surname> <given-names>G.</given-names></name></person-group> (<year>2003</year>). <article-title>The application of biofilm science to the study and control of chronic bacterial infections</article-title>. <source>J. Clin. Invest.</source> <volume>112</volume>, <fpage>1466</fpage>&#x02013;<lpage>1477</lpage>. <pub-id pub-id-type="doi">10.1172/JCI200320365</pub-id><pub-id pub-id-type="pmid">14617746</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dahl-Pedersen</surname> <given-names>K.</given-names></name> <name><surname>Bonde</surname> <given-names>M. K.</given-names></name> <name><surname>Herskin</surname> <given-names>M. S.</given-names></name> <name><surname>Jensen</surname> <given-names>K. H.</given-names></name> <name><surname>Kaiser</surname> <given-names>M.</given-names></name> <name><surname>Jensen</surname> <given-names>H. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Pathogenesis and pathology of shoulder ulcerations in sows with special reference to peripheral nerves and behavioural responses to palpation</article-title>. <source>Vet. J.</source> <volume>198</volume>, <fpage>666</fpage>&#x02013;<lpage>671</lpage>. <pub-id pub-id-type="doi">10.1016/j.tvjl.2013.09.059</pub-id><pub-id pub-id-type="pmid">24269106</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Damjanov</surname> <given-names>I.</given-names></name> <name><surname>Linder</surname> <given-names>J.</given-names></name></person-group> (<year>1996</year>). <source>Anderson&#x00027;s Pathology, 10th Edn</source>. <publisher-loc>St. Louis, MO</publisher-loc>: <publisher-name>Mosby</publisher-name>.</citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davey</surname> <given-names>M. E.</given-names></name> <name><surname>O&#x00027;toole</surname> <given-names>G. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Microbial biofilms: from ecology to molecular genetics</article-title>. <source>Microbiol. Mol. Biol. Rev.</source> <volume>64</volume>, <fpage>847</fpage>&#x02013;<lpage>867</lpage>. <pub-id pub-id-type="doi">10.1128/MMBR.64.4.847-867.2000</pub-id><pub-id pub-id-type="pmid">11104821</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>K.</given-names></name> <name><surname>Bills</surname> <given-names>J.</given-names></name> <name><surname>Barker</surname> <given-names>J.</given-names></name> <name><surname>Kim</surname> <given-names>P.</given-names></name> <name><surname>Lavery</surname> <given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>Simultaneous irrigation and negative pressure wound therapy enhances wound healing and reduces wound bioburden in a porcine model</article-title>. <source>Wound Repair Regen.</source> <volume>21</volume>, <fpage>869</fpage>&#x02013;<lpage>875</lpage>. <pub-id pub-id-type="doi">10.1111/wrr.12104</pub-id><pub-id pub-id-type="pmid">24134060</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>S. C.</given-names></name> <name><surname>Ricotti</surname> <given-names>C.</given-names></name> <name><surname>Cazzaniga</surname> <given-names>A.</given-names></name> <name><surname>Welsh</surname> <given-names>E.</given-names></name> <name><surname>Eaglstein</surname> <given-names>W. H.</given-names></name> <name><surname>Mertz</surname> <given-names>P. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Microscopic and physiologic evidence for biofilm-associated wound colonization <italic>in vivo</italic></article-title>. <source>Wound Repair Regen.</source> <volume>16</volume>, <fpage>23</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1111/j.1524-475X.2007.00303.x</pub-id><pub-id pub-id-type="pmid">18211576</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Dawson</surname> <given-names>H. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Chapter 22: A comparative assessment of the pig, mouse and human genomes</article-title>, in <source>The Minipig in Biomedical Research</source>, eds <person-group person-group-type="editor"><name><surname>McAnulty</surname> <given-names>P. A.</given-names></name> <name><surname>Dayan</surname> <given-names>A. D.</given-names></name> <name><surname>Ganderup</surname> <given-names>N.-C.</given-names></name> <name><surname>Hastings</surname> <given-names>K. L.</given-names></name></person-group> (<publisher-name>CRC Press</publisher-name>), <fpage>323</fpage>&#x02013;<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1201/b11356-28</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dewar</surname> <given-names>H. A.</given-names></name> <name><surname>Jones</surname> <given-names>M. R.</given-names></name> <name><surname>Griffin</surname> <given-names>S. G.</given-names></name> <name><surname>Oxley</surname> <given-names>A.</given-names></name> <name><surname>Marriner</surname> <given-names>J.</given-names></name></person-group> (<year>1987</year>). <article-title>A study of experimental endocarditis in pigs</article-title>. <source>J. Comp. Pathol.</source> <volume>97</volume>, <fpage>567</fpage>&#x02013;<lpage>574</lpage>. <pub-id pub-id-type="doi">10.1016/0021-9975(87)90007-7</pub-id><pub-id pub-id-type="pmid">3316315</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donlan</surname> <given-names>R. M.</given-names></name> <name><surname>Costerton</surname> <given-names>J. W.</given-names></name></person-group> (<year>2002</year>). <article-title>Biofilms: survival mechanisms of clinically relevant microorganisms</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>15</volume>, <fpage>167</fpage>&#x02013;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.15.2.167-193.2002</pub-id><pub-id pub-id-type="pmid">11932229</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Driskell</surname> <given-names>R.</given-names></name> <name><surname>Jahoda</surname> <given-names>C. A. B.</given-names></name> <name><surname>Chuong</surname> <given-names>C. M.</given-names></name> <name><surname>Watt</surname> <given-names>F.</given-names></name> <name><surname>Horsley</surname> <given-names>V.</given-names></name></person-group> (<year>2014</year>). <article-title>Defining dermal adipose tissue</article-title>. <source>Exp. Dermatol.</source> <volume>23</volume>, <fpage>629</fpage>&#x02013;<lpage>631</lpage>. <pub-id pub-id-type="doi">10.1111/exd.12450</pub-id><pub-id pub-id-type="pmid">24841073</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farhat</surname> <given-names>W.</given-names></name> <name><surname>Traubici</surname> <given-names>J.</given-names></name> <name><surname>Sherman</surname> <given-names>C.</given-names></name> <name><surname>Williams</surname> <given-names>T.</given-names></name> <name><surname>Babyn</surname> <given-names>P.</given-names></name> <name><surname>McLorie</surname> <given-names>G.</given-names></name></person-group> (<year>2002</year>). <article-title>Reliability of contrast enhanced sonography with harmonic imaging for detecting early renal scarring in experimental pyelonephritis in a porcine model: preliminary results</article-title>. <source>J. Urol.</source> <volume>168</volume>, <fpage>1114</fpage>&#x02013;<lpage>1117</lpage>. <pub-id pub-id-type="doi">10.1097/01.ju.0000025869.03295.79</pub-id><pub-id pub-id-type="pmid">12187247</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flemming</surname> <given-names>H. C.</given-names></name> <name><surname>Wingender</surname> <given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>The biofilm matrix</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>8</volume>, <fpage>623</fpage>&#x02013;<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2415</pub-id><pub-id pub-id-type="pmid">20676145</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geissinger</surname> <given-names>H. D.</given-names></name> <name><surname>Miniats</surname> <given-names>O. P.</given-names></name> <name><surname>Runhke</surname> <given-names>L. H.</given-names></name> <name><surname>Djurickovic</surname> <given-names>D. G.</given-names></name></person-group> (<year>1973</year>). <article-title>Experimental staphylococcal endocarditis in pigs: bacteriological, histopathological and scanning electron microscopic observations</article-title>. <source>J. Comp. Pathol.</source> <volume>83</volume>, <fpage>323</fpage>&#x02013;<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1016/0021-9975(73)90056-X</pub-id><pub-id pub-id-type="pmid">4727891</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghanbari</surname> <given-names>A.</given-names></name> <name><surname>Dehghany</surname> <given-names>J.</given-names></name> <name><surname>Schwebs</surname> <given-names>T.</given-names></name> <name><surname>M&#x000FC;sken</surname> <given-names>M.</given-names></name> <name><surname>H&#x000E4;ussler</surname> <given-names>S.</given-names></name> <name><surname>Meyer-Hermann</surname> <given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Inoculation density and nutrient level determine the formation of mushroom-shaped structures in <italic>Pseudomonas aeruginosa</italic> biofilms</article-title>. <source>Sci. Rep.</source> <volume>6</volume>:<fpage>32097</fpage>. <pub-id pub-id-type="doi">10.1038/srep32097</pub-id><pub-id pub-id-type="pmid">27611778</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Harris</surname> <given-names>D. L.</given-names></name> <name><surname>Alexander</surname> <given-names>T. J. L.</given-names></name></person-group> (<year>1999</year>). <article-title>Methods of disease control</article-title>, in <person-group person-group-type="editor"><name><surname>Straw</surname> <given-names>B. E.</given-names></name> <name><surname>Dallaire</surname> <given-names>S. Y.</given-names></name> <name><surname>Mengeling</surname> <given-names>W. L.</given-names></name> <name><surname>Taylor</surname> <given-names>D. J.</given-names></name></person-group> <italic>Diseases of Swine, 8th Edn</italic> (<publisher-loc>Iowa, IA</publisher-loc>: <publisher-name>Iowa State University Press</publisher-name>), <fpage>1077</fpage>.</citation></ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname> <given-names>T.</given-names></name> <name><surname>Spielmann</surname> <given-names>M.</given-names></name> <name><surname>Zuhaili</surname> <given-names>B.</given-names></name> <name><surname>Koehler</surname> <given-names>T.</given-names></name> <name><surname>Fossum</surname> <given-names>M.</given-names></name> <name><surname>Steinau</surname> <given-names>H.-U.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Enhanced susceptibility to infections in a diabetic wound healing model</article-title>. <source>BMC Surg.</source> <volume>8</volume>:<fpage>5</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2482-8-5</pub-id><pub-id pub-id-type="pmid">18312623</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hodson</surname> <given-names>C. J.</given-names></name> <name><surname>Maling</surname> <given-names>T. M.</given-names></name> <name><surname>McManamom</surname> <given-names>P. J.</given-names></name> <name><surname>Lewis</surname> <given-names>M. G.</given-names></name></person-group> (<year>1975</year>). <article-title>The pathogenesis of reflux nephropathy (Chronic atrophic pyelonephritis)</article-title>. <source>Br. J. Radiol.</source> <volume>13</volume>, <fpage>1</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="pmid">766885</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname> <given-names>Z.</given-names></name> <name><surname>Busch</surname> <given-names>J.</given-names></name> <name><surname>Awwad</surname> <given-names>M.</given-names></name> <name><surname>Wagner</surname> <given-names>R.</given-names></name> <name><surname>Wells</surname> <given-names>K.</given-names></name> <name><surname>Cooper</surname> <given-names>D. K.</given-names></name></person-group> (<year>2006</year>). <article-title>Selected physiologic compatibilities and incompatibilities between human and porcine organ systems</article-title>. <source>Xenotransplantation</source> <volume>13</volume>, <fpage>488</fpage>&#x02013;<lpage>499</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-3089.2006.00346.x</pub-id><pub-id pub-id-type="pmid">17059572</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Isling</surname> <given-names>L. K.</given-names></name> <name><surname>Aalb&#x000E6;k</surname> <given-names>B.</given-names></name> <name><surname>Birck</surname> <given-names>M. M.</given-names></name> <name><surname>Heegaard</surname> <given-names>P. M. H.</given-names></name> <name><surname>Leifsson</surname> <given-names>P. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Host response to porcine strains of <italic>Escherichia coli</italic> in a novel pyelonephritis model</article-title>. <source>J. Comp. Pathol.</source> <volume>144</volume>, <fpage>257</fpage>&#x02013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcpa.2010.10.002</pub-id><pub-id pub-id-type="pmid">21159351</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname> <given-names>H. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Investigation into the pathology of shoulder ulcerations in sows</article-title>. <source>Vet. Rec.</source> <volume>165</volume>, <fpage>171</fpage>&#x02013;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1136/vr.165.6.171</pub-id><pub-id pub-id-type="pmid">19666915</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname> <given-names>H. E.</given-names></name> <name><surname>Gyllensten</surname> <given-names>J.</given-names></name> <name><surname>Hofman</surname> <given-names>C.</given-names></name> <name><surname>Leifsson</surname> <given-names>P. S.</given-names></name> <name><surname>Agerholm</surname> <given-names>J. S.</given-names></name> <name><surname>Boye</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2010a</year>). <article-title>Histologic and bacteriologic findings in valvular endocarditis of slaughter-age pigs</article-title>. <source>J. Vet. Diagn. Invest.</source> <volume>22</volume>, <fpage>921</fpage>&#x02013;<lpage>927</lpage>. <pub-id pub-id-type="doi">10.1177/104063871002200611</pub-id><pub-id pub-id-type="pmid">21088176</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname> <given-names>H. E.</given-names></name> <name><surname>Nielsen</surname> <given-names>O. L.</given-names></name> <name><surname>Agerholm</surname> <given-names>J. S.</given-names></name> <name><surname>Iburg</surname> <given-names>T.</given-names></name> <name><surname>Johansen</surname> <given-names>L. K.</given-names></name> <name><surname>Johannesson</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2010b</year>). <article-title>A non-traumatic <italic>Staphylococcus aureus</italic> osteomyelitis model in pigs</article-title>. <source>in vivo</source> <volume>24</volume>, <fpage>257</fpage>&#x02013;<lpage>264</lpage>. <pub-id pub-id-type="pmid">20554996</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname> <given-names>L. K.</given-names></name> <name><surname>Koch</surname> <given-names>J.</given-names></name> <name><surname>Aalb&#x000E6;k</surname> <given-names>B.</given-names></name> <name><surname>Moodley</surname> <given-names>A.</given-names></name> <name><surname>Bjarnsholt</surname> <given-names>T.</given-names></name> <name><surname>Kragh</surname> <given-names>K. N.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Early implant-associated osteomyelitis results in a peri-implanted bacterial reservoir</article-title>. <source>APMIS</source> <volume>125</volume>, <fpage>38</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1111/apm.12597</pub-id><pub-id pub-id-type="pmid">27704604</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname> <given-names>L. K.</given-names></name> <name><surname>Koch</surname> <given-names>J.</given-names></name> <name><surname>Dich-Jorgensen</surname> <given-names>K.</given-names></name> <name><surname>Aalbaek</surname> <given-names>B.</given-names></name> <name><surname>Petersen</surname> <given-names>A.</given-names></name> <name><surname>Fuursted</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Novel porcine model of implant-associated osteomyelitis: a comprehensive analysis of local, regional, and systemic response</article-title>. <source>J. Orthop. Res.</source> <volume>35</volume>, <fpage>2211</fpage>&#x02013;<lpage>2221</lpage>. <pub-id pub-id-type="doi">10.1002/jor.23505</pub-id><pub-id pub-id-type="pmid">27958656</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname> <given-names>L. K.</given-names></name> <name><surname>Frees</surname> <given-names>D.</given-names></name> <name><surname>Aalb&#x000E6;k</surname> <given-names>B.</given-names></name> <name><surname>Koch</surname> <given-names>J.</given-names></name> <name><surname>Iburg</surname> <given-names>T.</given-names></name> <name><surname>Nielsen</surname> <given-names>O. L.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>A porcine model of acute, haematogenous, localized osteomyelitis due to <italic>Staphylococcus aureus</italic>: a pathomorphological study</article-title>. <source>APMIS</source> <volume>119</volume>, <fpage>111</fpage>&#x02013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0463.2010.02700.x</pub-id><pub-id pub-id-type="pmid">21208278</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname> <given-names>L. K.</given-names></name> <name><surname>Koch</surname> <given-names>J.</given-names></name> <name><surname>Frees</surname> <given-names>D.</given-names></name> <name><surname>Aalb&#x000E6;k</surname> <given-names>B.</given-names></name> <name><surname>Nielsen</surname> <given-names>O.</given-names></name> <name><surname>Leifsson</surname> <given-names>P. S.</given-names></name> <etal/></person-group>. (<year>2012a</year>). <article-title>Pathology and biofilm formation in a porcine model of staphylococcal osteomyelitis</article-title>. <source>J. Comp. Pathol.</source> <volume>147</volume>, <fpage>343</fpage>&#x02013;<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcpa.2012.01.018</pub-id><pub-id pub-id-type="pmid">22534025</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname> <given-names>L. K.</given-names></name> <name><surname>Koch</surname> <given-names>J.</given-names></name> <name><surname>Kirketerp-Moller</surname> <given-names>K.</given-names></name> <name><surname>Wamsler</surname> <given-names>O. J.</given-names></name> <name><surname>Nielsen</surname> <given-names>O. L.</given-names></name> <name><surname>Leifsson</surname> <given-names>P. S.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Therapy of haematogenous osteomyelitis - A comparative study in a porcine model and angolan children</article-title>. <source>in vivo</source> <volume>27</volume>, <fpage>305</fpage>&#x02013;<lpage>312</lpage>. <pub-id pub-id-type="pmid">23606685</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname> <given-names>L. K.</given-names></name> <name><surname>Svalastoga</surname> <given-names>E. L.</given-names></name> <name><surname>Frees</surname> <given-names>D.</given-names></name> <name><surname>Aalb&#x000E6;k</surname> <given-names>B.</given-names></name> <name><surname>Koch</surname> <given-names>J.</given-names></name> <name><surname>Iburg</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2012b</year>). <article-title>A new technique for modeling of hematogenous osteomyelitis in pigs: inoculation into femoral artery</article-title>. <source>J. Invest. Surg.</source> <volume>26</volume>, <fpage>149</fpage>&#x02013;<lpage>153</lpage>. <pub-id pub-id-type="doi">10.3109/08941939.2012.718043</pub-id><pub-id pub-id-type="pmid">23273181</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>C. M.</given-names></name> <name><surname>Bahn</surname> <given-names>R. C.</given-names></name> <name><surname>Fass</surname> <given-names>D. N.</given-names></name></person-group> (<year>1986</year>). <article-title>Experimental porcine infective endocarditis: description of a clinical model</article-title>. <source>Vet. Pathol.</source> <volume>23</volume>, <fpage>780</fpage>&#x02013;<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1177/030098588602300620</pub-id><pub-id pub-id-type="pmid">3811145</pub-id></citation></ref>
<ref id="B45">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>J. E. T.</given-names></name></person-group> (<year>1969</year>). <article-title>The experimental production of streptococcal endocarditis in the pig</article-title>. <source>J. Pathol.</source> <volume>99</volume>, <fpage>307</fpage>&#x02013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1002/path.1710990406</pub-id><pub-id pub-id-type="pmid">5401242</pub-id></citation></ref>
<ref id="B46">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>J. E. T.</given-names></name></person-group> (<year>1981</year>). <article-title>Experimental streptococcal endocarditis in the pig: the development of lesions 3 to 14 days after inoculation</article-title>. <source>J. Comp. Pathol.</source> <volume>91</volume>, <fpage>51</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/0021-9975(81)90044-X</pub-id><pub-id pub-id-type="pmid">7343575</pub-id></citation></ref>
<ref id="B47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>J. E. T.</given-names></name></person-group> (<year>1982</year>). <article-title>Experimental streptococcal endocarditis in the pig: the development of lesions 18 to 48 hours after inoculation</article-title>. <source>J. Comp. Pathol.</source> <volume>92</volume>, <fpage>301</fpage>&#x02013;<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1016/0021-9975(82)90089-5</pub-id><pub-id pub-id-type="pmid">7085946</pub-id></citation></ref>
<ref id="B48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>H. K.</given-names></name> <name><surname>Thammavongsa</surname> <given-names>V.</given-names></name> <name><surname>Schneewind</surname> <given-names>O.</given-names></name> <name><surname>Missiakas</surname> <given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Recurrent infections and immune evasion strategies of <italic>Staphylococcus aureus</italic></article-title>. <source>Curr. Opin. Microbiol.</source> <volume>15</volume>, <fpage>92</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2011.10.012</pub-id><pub-id pub-id-type="pmid">22088393</pub-id></citation></ref>
<ref id="B49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirketerp-M&#x000F8;ller</surname> <given-names>K.</given-names></name> <name><surname>Jensen</surname> <given-names>P.</given-names></name> <name><surname>Fazli</surname> <given-names>M.</given-names></name> <name><surname>Madsen</surname> <given-names>K. G.</given-names></name> <name><surname>Pedersen</surname> <given-names>J.</given-names></name> <name><surname>Moser</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Distribution, organization, and ecology of bacteria in chronic wounds</article-title>. <source>J. Clin. Microbiol.</source> <volume>46</volume>, <fpage>2717</fpage>&#x02013;<lpage>2722</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.00501-08</pub-id><pub-id pub-id-type="pmid">18508940</pub-id></citation></ref>
<ref id="B50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koschmieder</surname> <given-names>R.</given-names></name> <name><surname>Ritzerfeld</surname> <given-names>W.</given-names></name> <name><surname>Homeyer</surname> <given-names>L.</given-names></name></person-group> (<year>1975</year>). <article-title>Gentamycinzusatz zum polymethylmethacrylat zur behandlung von knocheninfektionen</article-title>. <source>Z. Orthop.</source> <volume>113</volume>, <fpage>147</fpage>&#x02013;<lpage>149</lpage>.</citation></ref>
<ref id="B51">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lebeaux</surname> <given-names>D.</given-names></name> <name><surname>Chauhan</surname> <given-names>A.</given-names></name> <name><surname>Rendueles</surname> <given-names>O.</given-names></name> <name><surname>Beloin</surname> <given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>From <italic>in vitro</italic> to <italic>in vivo</italic> models of bacterial biofilm-related infections</article-title>. <source>Pathogens</source> <volume>2</volume>, <fpage>288</fpage>&#x02013;<lpage>356</lpage>. <pub-id pub-id-type="doi">10.3390/pathogens2020288</pub-id><pub-id pub-id-type="pmid">25437038</pub-id></citation></ref>
<ref id="B52">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lew</surname> <given-names>D. P.</given-names></name> <name><surname>Waldvogel</surname> <given-names>F. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Osteomyelitis</article-title>. <source>Lancet</source> <volume>364</volume>, <fpage>369</fpage>&#x02013;<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(04)16727-5</pub-id><pub-id pub-id-type="pmid">15276398</pub-id></citation></ref>
<ref id="B53">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>J. Y.</given-names></name> <name><surname>Shang</surname> <given-names>H. T.</given-names></name> <name><surname>Liu</surname> <given-names>C. E.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Niu</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Light microscopic, electron microscopic, and immunohistochemical comparison of bama minipig (sus scrofa domestica) and human skin</article-title>. <source>Comp. Med.</source> <volume>60</volume>, <fpage>142</fpage>&#x02013;<lpage>148</lpage>. <pub-id pub-id-type="pmid">20412690</pub-id></citation></ref>
<ref id="B54">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lund</surname> <given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Skulders&#x000E5;r hos s&#x000F8;er [Shoulder ulcerations in sows]</article-title>. <source>Danish Veterinary Record</source> <volume>22</volume>, <fpage>8</fpage>&#x02013;<lpage>11</lpage>.</citation></ref>
<ref id="B55">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Maxie</surname> <given-names>M. G.</given-names></name></person-group> (<year>2007</year>). <source>Pathology of Domestic Animals, 5th Edn</source>. <publisher-loc>Great Britain</publisher-loc>: <publisher-name>Elsevier</publisher-name>.</citation></ref>
<ref id="B56">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname> <given-names>A.</given-names></name> <name><surname>Scott</surname> <given-names>P. G.</given-names></name> <name><surname>Ghahary</surname> <given-names>A.</given-names></name> <name><surname>Tredget</surname> <given-names>E. E.</given-names></name></person-group> (<year>2005</year>). <article-title>Pathophysiology of chronic nonhealing wounds</article-title>. <source>J. Burn Care Rehabil.</source> <volume>26</volume>, <fpage>306</fpage>&#x02013;<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1097/01.BCR.0000169887.04973.3A</pub-id><pub-id pub-id-type="pmid">16006837</pub-id></citation></ref>
<ref id="B57">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meurens</surname> <given-names>F.</given-names></name> <name><surname>Summerfield</surname> <given-names>A.</given-names></name> <name><surname>Nauwynck</surname> <given-names>H.</given-names></name> <name><surname>Saif</surname> <given-names>L.</given-names></name> <name><surname>Gerdts</surname> <given-names>V.</given-names></name></person-group> (<year>2012</year>). <article-title>The pig: a model for human infectious diseases</article-title>. <source>Trends Microbiol.</source> <volume>20</volume>, <fpage>50</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2011.11.002</pub-id><pub-id pub-id-type="pmid">22153753</pub-id></citation></ref>
<ref id="B58">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morawietz</surname> <given-names>L.</given-names></name> <name><surname>Classen</surname> <given-names>R. A.</given-names></name> <name><surname>Schroder</surname> <given-names>J. H.</given-names></name> <name><surname>Dynybil</surname> <given-names>C.</given-names></name> <name><surname>Perka</surname> <given-names>C.</given-names></name> <name><surname>Skwara</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Proposal for a histopathological consensus classification of the periprosthetic interface membrane</article-title>. <source>J. Clin. Pathol.</source> <volume>59</volume>, <fpage>591</fpage>&#x02013;<lpage>597</lpage>. <pub-id pub-id-type="doi">10.1136/jcp.2005.027458</pub-id><pub-id pub-id-type="pmid">16731601</pub-id></citation></ref>
<ref id="B59">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murdoch</surname> <given-names>D. R.</given-names></name> <name><surname>Corey</surname> <given-names>G. R.</given-names></name> <name><surname>Hoen</surname> <given-names>B.</given-names></name> <name><surname>Mir&#x000F3;</surname> <given-names>J.</given-names></name> <name><surname>Fowler</surname> <given-names>V. G.</given-names> <suffix>Jr.</suffix></name> <name><surname>Bayer</surname> <given-names>A. S.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century</article-title>. <source>Arch. Intern. Med.</source> <volume>169</volume>, <fpage>463</fpage>&#x02013;<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1001/archinternmed.2008.603</pub-id><pub-id pub-id-type="pmid">19273776</pub-id></citation></ref>
<ref id="B60">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nusbaum</surname> <given-names>A. G.</given-names></name> <name><surname>Gil</surname> <given-names>J.</given-names></name> <name><surname>Rippy</surname> <given-names>M. K.</given-names></name> <name><surname>Warne</surname> <given-names>B.</given-names></name> <name><surname>Valdes</surname> <given-names>J.</given-names></name> <name><surname>Claro</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Effective method to remove wound bacteria: comparison of various debridement modalities in an <italic>in vivo</italic> porcine model</article-title>. <source>J. Surg. Res.</source> <volume>176</volume>, <fpage>701</fpage>&#x02013;<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1016/j.jss.2011.11.1040</pub-id><pub-id pub-id-type="pmid">22440935</pub-id></citation></ref>
<ref id="B61">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname> <given-names>A. L.</given-names></name> <name><surname>Galloway</surname> <given-names>R. H.</given-names></name> <name><surname>Baumgartner</surname> <given-names>J. C.</given-names></name> <name><surname>Barsoum</surname> <given-names>I. S.</given-names></name></person-group> (<year>1993</year>). <article-title>Development of chronic mandibular osteomyelitis in a miniswine model</article-title>. <source>J. Oral Maxillofac. Surg.</source> <volume>51</volume>, <fpage>1358</fpage>&#x02013;<lpage>1362</lpage>. <pub-id pub-id-type="doi">10.1016/S0278-2391(10)80142-9</pub-id><pub-id pub-id-type="pmid">8229416</pub-id></citation></ref>
<ref id="B62">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pearce</surname> <given-names>A. I.</given-names></name> <name><surname>Richards</surname> <given-names>R. G.</given-names></name> <name><surname>Milz</surname> <given-names>S.</given-names></name> <name><surname>Schneider</surname> <given-names>E.</given-names></name> <name><surname>Pearce</surname> <given-names>S. G.</given-names></name></person-group> (<year>2007</year>). <article-title>Animal models for implant biomaterial research in bone: a review</article-title>. <source>Eur. Cells Mater.</source> <volume>13</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.22203/eCM.v013a01</pub-id><pub-id pub-id-type="pmid">17334975</pub-id></citation></ref>
<ref id="B63">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pracy</surname> <given-names>J. P.</given-names></name> <name><surname>White</surname> <given-names>A.</given-names></name> <name><surname>Mustafa</surname> <given-names>Y.</given-names></name> <name><surname>Smith</surname> <given-names>D.</given-names></name> <name><surname>Perry</surname> <given-names>M. E.</given-names></name></person-group> (<year>1998</year>). <article-title>The comparative anatomy of the pig middle ear cavity: a model for middle ear inflammation in the human?</article-title> <source>J. Anat.</source> <volume>192</volume>, <fpage>359</fpage>&#x02013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1046/j.1469-7580.1998.19230359.x</pub-id><pub-id pub-id-type="pmid">9688502</pub-id></citation></ref>
<ref id="B64">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ransley</surname> <given-names>P. G.</given-names></name> <name><surname>Risdon</surname> <given-names>R. A.</given-names></name></person-group> (<year>1981</year>). <article-title>Reflux nephropathy: effects of antimicrobial therapy on the evolution of the early pyelonephritic scar</article-title>. <source>Kidney Int.</source> <volume>20</volume>, <fpage>733</fpage>&#x02013;<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1038/ki.1981.204</pub-id><pub-id pub-id-type="pmid">7038262</pub-id></citation></ref>
<ref id="B65">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reizner</surname> <given-names>W.</given-names></name> <name><surname>Hunter</surname> <given-names>J. G.</given-names></name> <name><surname>O&#x00027;Malley</surname> <given-names>N. T.</given-names></name> <name><surname>Southgate</surname> <given-names>R. D.</given-names></name> <name><surname>Schwarz</surname> <given-names>E. M.</given-names></name> <name><surname>Kates</surname> <given-names>S. L.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>A systematic review of animal models for <italic>Staphylococcus aureus</italic> osteomyelitis</article-title>. <source>Eur. Cells Mater.</source> <volume>27</volume>, <fpage>196</fpage>&#x02013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.22203/eCM.v027a15</pub-id><pub-id pub-id-type="pmid">24668594</pub-id></citation></ref>
<ref id="B66">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rink</surname> <given-names>A.</given-names></name> <name><surname>Santschi</surname> <given-names>E. M.</given-names></name> <name><surname>Beattie</surname> <given-names>C. W.</given-names></name></person-group> (<year>2001</year>). <article-title>Normalized cDNA libraries from a porcine model of orthopedic implant-associated infection</article-title>. <source>Mamm. Genome</source> <volume>13</volume>, <fpage>198</fpage>&#x02013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-001-2120-0</pub-id><pub-id pub-id-type="pmid">11956763</pub-id></citation></ref>
<ref id="B67">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname> <given-names>A. E. L.</given-names></name> <name><surname>Kragh</surname> <given-names>K. N.</given-names></name> <name><surname>Bjarnsholt</surname> <given-names>T.</given-names></name> <name><surname>Diggle</surname> <given-names>S. P.</given-names></name></person-group> (<year>2015</year>). <article-title>The limitations of <italic>in vitro</italic> experimentation in understanding biofilms and chronic infection</article-title>. <source>J. Mol. Biol.</source> <volume>427</volume>, <fpage>3646</fpage>&#x02013;<lpage>3661</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2015.09.002</pub-id><pub-id pub-id-type="pmid">26344834</pub-id></citation></ref>
<ref id="B68">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roche</surname> <given-names>E. D.</given-names></name> <name><surname>Renick</surname> <given-names>P. J.</given-names></name> <name><surname>Tetens</surname> <given-names>S. P.</given-names></name> <name><surname>Ramsay</surname> <given-names>S. J.</given-names></name> <name><surname>Daniels</surname> <given-names>E. Q.</given-names></name> <name><surname>Carson</surname> <given-names>D. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Increasing the presence of biofilm and healing delay in a porcine model of MRSA-infected wounds</article-title>. <source>Wound Repair Regen.</source> <volume>20</volume>, <fpage>537</fpage>&#x02013;<lpage>543</lpage>. <pub-id pub-id-type="doi">10.1111/j.1524-475X.2012.00808.x</pub-id><pub-id pub-id-type="pmid">22672311</pub-id></citation></ref>
<ref id="B69">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Rumbaugh</surname> <given-names>K. P.</given-names></name> <name><surname>Carty</surname> <given-names>N. L.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>In vivo</italic> model of biofilm infections</article-title>, in <source>Biofilm Infections</source>, eds <person-group person-group-type="editor"><name><surname>Bjarnsholt</surname> <given-names>T.</given-names></name> <name><surname>Jensen</surname> <given-names>P.</given-names></name> <name><surname>Moser</surname> <given-names>C.</given-names></name> <name><surname>H&#x000F8;iby</surname> <given-names>N.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-loc>Springer</publisher-loc>), <fpage>267</fpage>&#x02013;<lpage>290</lpage>.</citation></ref>
<ref id="B70">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schomberg</surname> <given-names>D. T.</given-names></name> <name><surname>Tellez</surname> <given-names>A.</given-names></name> <name><surname>Meudt</surname> <given-names>J. J.</given-names></name> <name><surname>Brady</surname> <given-names>D. A.</given-names></name> <name><surname>Dillon</surname> <given-names>K. N.</given-names></name> <name><surname>Arowolo</surname> <given-names>F. K.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Miniature swine for preclinical modeling of complexities of human disease for translational scientific discovery and accelerated development of therapies and medical devices</article-title>. <source>Toxicol. Pathol.</source> <volume>44</volume>, <fpage>299</fpage>&#x02013;<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1177/0192623315618292</pub-id><pub-id pub-id-type="pmid">26839324</pub-id></citation></ref>
<ref id="B71">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seaton</surname> <given-names>M.</given-names></name> <name><surname>Hocking</surname> <given-names>A.</given-names></name> <name><surname>Gibran</surname> <given-names>N. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Porcine models of cutaneous wound healing</article-title>. <source>ILAR J.</source> <volume>56</volume>, <fpage>127</fpage>&#x02013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1093/ilar/ilv016</pub-id><pub-id pub-id-type="pmid">25991704</pub-id></citation></ref>
<ref id="B72">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname> <given-names>P. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Biophysics of biofilm infection</article-title>. <source>Pathog. Dis.</source> <volume>70</volume>, <fpage>212</fpage>&#x02013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1111/2049-632X.12118</pub-id><pub-id pub-id-type="pmid">24376149</pub-id></citation></ref>
<ref id="B73">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>T. P.</given-names></name> <name><surname>Eaglstein</surname> <given-names>W. H.</given-names></name> <name><surname>Davis</surname> <given-names>S. C.</given-names></name> <name><surname>Mertz</surname> <given-names>P.</given-names></name></person-group> (<year>2001</year>). <article-title>The pig as a model for human wound healing</article-title>. <source>Wound Repair Regen.</source> <volume>9</volume>, <fpage>66</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1046/j.1524-475x.2001.00066.x</pub-id><pub-id pub-id-type="pmid">11350644</pub-id></citation></ref>
<ref id="B74">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Swindle</surname> <given-names>M. M.</given-names></name> <name><surname>Smith</surname> <given-names>A. C.</given-names></name></person-group> (<year>1998</year>). <article-title>Comparative anatomy and physiology of the pig</article-title>, in <source>Information Resources on Swine in Biomedical Research 1990-2000</source>, Vol. <volume>25</volume>, ed <person-group person-group-type="editor"><name><surname>Smith</surname> <given-names>C. P.</given-names></name></person-group> (<publisher-loc>Beltsville, MD</publisher-loc>: <publisher-name>United States Department of Agriculture, Agricultural Research Service, National Agricultural Library, Animal Welfare Information Center</publisher-name>), <fpage>11</fpage>&#x02013;<lpage>21</lpage>.</citation></ref>
<ref id="B75">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swindle</surname> <given-names>M. M.</given-names></name> <name><surname>Makin</surname> <given-names>A.</given-names></name> <name><surname>Herron</surname> <given-names>A. J.</given-names></name> <name><surname>Clubb</surname> <given-names>F. J.</given-names></name> <name><surname>Frazier</surname> <given-names>K. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Swine as models in biomedical research and toxicology testing</article-title>. <source>Vet. Pathol.</source> <volume>49</volume>, <fpage>344</fpage>&#x02013;<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1177/0300985811402846</pub-id><pub-id pub-id-type="pmid">21441112</pub-id></citation></ref>
<ref id="B76">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>T&#x000F8;ttrup</surname> <given-names>M.</given-names></name> <name><surname>Bue</surname> <given-names>M.</given-names></name> <name><surname>Koch</surname> <given-names>J.</given-names></name> <name><surname>Jensen</surname> <given-names>L. K.</given-names></name> <name><surname>Hanberg</surname> <given-names>P.</given-names></name> <name><surname>Aalb&#x000E6;k</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Effects of implant-associated osteomyelitis on cefuroxime bone pharmacokinetics: assessment in a porcine model</article-title>. <source>J. Bone Joint Surg. Am.</source> <volume>2</volume>, <fpage>363</fpage>&#x02013;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.2106/JBJS.O.00550</pub-id></citation></ref>
<ref id="B77">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname> <given-names>Y. D. N.</given-names></name> <name><surname>Labrie</surname> <given-names>J.</given-names></name> <name><surname>Ch&#x000E9;nier</surname> <given-names>S.</given-names></name> <name><surname>Jacques</surname> <given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Actinobacillus pleuropneumoniae grows as aggregates in the lung of pigs: is it time to refine our <italic>in vitro</italic> biofilm assays?</article-title> <source>Microb. Biotechnol.</source> <volume>10</volume>, <fpage>756</fpage>&#x02013;<lpage>760</lpage>. <pub-id pub-id-type="doi">10.1111/1751-7915.12432</pub-id><pub-id pub-id-type="pmid">27790837</pub-id></citation></ref>
<ref id="B78">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname> <given-names>R. L.</given-names></name> <name><surname>Cutlip</surname> <given-names>R. C.</given-names></name> <name><surname>Shuman</surname> <given-names>R. D.</given-names></name></person-group> (<year>1971</year>). <article-title>Osteomyelitis and arthritis induced in swine by Lancefield&#x00027;s group A streptococci (<italic>Streptococcus pyogenes</italic>)</article-title>. <source>Cornell Vet.</source> <volume>61</volume>, <fpage>457</fpage>&#x02013;<lpage>470</lpage>. <pub-id pub-id-type="pmid">5568280</pub-id></citation></ref>
<ref id="B79">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Q.</given-names></name> <name><surname>Larose</surname> <given-names>C.</given-names></name> <name><surname>Della Porta</surname> <given-names>A. C.</given-names></name> <name><surname>Schultz</surname> <given-names>G. S.</given-names></name> <name><surname>Gibson</surname> <given-names>D. J.</given-names></name></person-group> (<year>2017</year>). <article-title>A surfactant-based wound dressing can reduce bacterial biofilms in a porcine skin explant model</article-title>. <source>Int. Wound J.</source> <volume>14</volume>, <fpage>408</fpage>&#x02013;<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1111/iwj.12619</pub-id><pub-id pub-id-type="pmid">27212453</pub-id></citation></ref>
<ref id="B80">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Zachary</surname> <given-names>J. F.</given-names></name></person-group> (<year>2017</year>). <source>Pathologic Basis of Veterinary Disease, 6th Edn</source>. <publisher-loc>St. Louis, MO</publisher-loc>: <publisher-name>Elsevier</publisher-name>.</citation></ref>
<ref id="B81">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zimmerli</surname> <given-names>W.</given-names></name> <name><surname>Trampuz</surname> <given-names>A.</given-names></name> <name><surname>Ochsner</surname> <given-names>P. E.</given-names></name></person-group> (<year>2004</year>). <article-title>Prosthetic-joint infections</article-title>. <source>N. Engl. J. Med.</source> <volume>351</volume>, <fpage>1645</fpage>&#x02013;<lpage>1654</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra040181</pub-id><pub-id pub-id-type="pmid">15483283</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This review was financed by grant no. 4005-00035B from the Danish Research Council and the European Union&#x00027;s Horizon 2020 research and innovation program under NOMORFILM project grant agreement No 634588.</p>
</fn>
</fn-group>
</back>
</article>